1
|
Goessinger EV, Cerminara SE, Mueller AM, Gottfrois P, Huber S, Amaral M, Wenz F, Kostner L, Weiss L, Kunz M, Maul JT, Wespi S, Broman E, Kaufmann S, Patpanathapillai V, Treyer I, Navarini AA, Maul LV. Consistency of convolutional neural networks in dermoscopic melanoma recognition: A prospective real-world study about the pitfalls of augmented intelligence. J Eur Acad Dermatol Venereol 2024; 38:945-953. [PMID: 38158385 DOI: 10.1111/jdv.19777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2023] [Accepted: 10/23/2023] [Indexed: 01/03/2024]
Abstract
BACKGROUND Deep-learning convolutional neural networks (CNNs) have outperformed even experienced dermatologists in dermoscopic melanoma detection under controlled conditions. It remains unexplored how real-world dermoscopic image transformations affect CNN robustness. OBJECTIVES To investigate the consistency of melanoma risk assessment by two commercially available CNNs to help formulate recommendations for current clinical use. METHODS A comparative cohort study was conducted from January to July 2022 at the Department of Dermatology, University Hospital Basel. Five dermoscopic images of 116 different lesions on the torso of 66 patients were captured consecutively by the same operator without deliberate rotation. Classification was performed by two CNNs (CNN-1/CNN-2). Lesions were divided into four subgroups based on their initial risk scoring and clinical dignity assessment. Reliability was assessed by variation and intraclass correlation coefficients. Excisions were performed for melanoma suspicion or two consecutively elevated CNN risk scores, and benign lesions were confirmed by expert consensus (n = 3). RESULTS 117 repeated image series of 116 melanocytic lesions (2 melanomas, 16 dysplastic naevi, 29 naevi, 1 solar lentigo, 1 suspicious and 67 benign) were classified. CNN-1 demonstrated superior measurement repeatability for clinically benign lesions with an initial malignant risk score (mean variation coefficient (mvc): CNN-1: 49.5(±34.3)%; CNN-2: 71.4(±22.5)%; p = 0.03), while CNN-2 outperformed for clinically benign lesions with benign scoring (mvc: CNN-1: 49.7(±22.7)%; CNN-2: 23.8(±29.3)%; p = 0.002). Both systems exhibited lowest score consistency for lesions with an initial malignant risk score and benign assessment. In this context, averaging three initial risk scores achieved highest sensitivity of dignity assessment (CNN-1: 94%; CNN-2: 89%). Intraclass correlation coefficients indicated 'moderate'-to-'good' reliability for both systems (CNN-1: 0.80, 95% CI:0.71-0.87, p < 0.001; CNN-2: 0.67, 95% CI:0.55-0.77, p < 0.001). CONCLUSIONS Potential user-induced image changes can significantly influence CNN classification. For clinical application, we recommend using the average of three initial risk scores. Furthermore, we advocate for CNN robustness optimization by cross-validation with repeated image sets. TRIAL REGISTRATION ClinicalTrials.gov (NCT04605822).
Collapse
Affiliation(s)
- E V Goessinger
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - S E Cerminara
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - A M Mueller
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - P Gottfrois
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - S Huber
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - M Amaral
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - F Wenz
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - L Kostner
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - L Weiss
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - M Kunz
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - J-T Maul
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
| | - S Wespi
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - E Broman
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - S Kaufmann
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - V Patpanathapillai
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - I Treyer
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - A A Navarini
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
| | - L V Maul
- Department of Dermatology, University Hospital Basel, Basel, Switzerland
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
| |
Collapse
|
2
|
Karras F, Bonsack M, Seifert S, Friedrich L, Kunz M. MEK inhibition induces expression of differentiation marker Keratin 10 in human keratinocytes. Pathol Res Pract 2023; 250:154788. [PMID: 37729782 DOI: 10.1016/j.prp.2023.154788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Revised: 08/29/2023] [Accepted: 09/01/2023] [Indexed: 09/22/2023]
Abstract
BRAF mutant metastatic melanoma was regularly treated in the past with a BRAF inhibitor (BRAFi) alone or in combination with inhibitors of the mitogen-activated protein kinase kinase (MEKi), which is still a common treatment. This combination therapy strongly reduced the occurrence of keratoacanthomas and squamous cell carcinoma, which was frequently seen when BRAFi was used as monotherapy. Here we addressed the question whether MEK inhibition counteracts squamous cell carcinoma development in part by promoting keratinocyte differentiation. Exposure of human immortalized keratinocytes to different concentrations of MEKi revealed a significant increase in the expression of differentiation-associated keratins K10 and K1 as determined by qRT-PCR and immunofluorescence staining. Taken together, the present study suggests that in a combined treatment of melanoma with BRAFi/MEKi, MEKi reduces the incidence of squamous cell carcinomas by promoting keratinocyte differentiation under combined BRAFi/MEKi treatment in melanoma. This might open further treatment perspectives for skin cancer treatment.
Collapse
Affiliation(s)
- F Karras
- Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, 04103 Leipzig, Germany; Institute of Pathology, University Hospital Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany.
| | - M Bonsack
- Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, 04103 Leipzig, Germany
| | - S Seifert
- Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, 04103 Leipzig, Germany
| | - L Friedrich
- Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, 04103 Leipzig, Germany
| | - M Kunz
- Department of Dermatology, Venereology and Allergology, University Medical Center Leipzig, 04103 Leipzig, Germany
| |
Collapse
|
3
|
Abstract
Anomaly detection is challenging, especially for large datasets in high dimensions. Here, we explore a general anomaly detection framework based on dimensionality reduction and unsupervised clustering. DRAMA is released as a general python package that implements the general framework with a wide range of built-in options. This approach identifies the primary prototypes in the data with anomalies detected by their large distances from the prototypes, either in the latent space or in the original, high-dimensional space. DRAMA is tested on a wide variety of simulated and real datasets, in up to 3000 dimensions, and is found to be robust and highly competitive with commonly used anomaly detection algorithms, especially in high dimensions. The flexibility of the DRAMA framework allows for significant optimization once some examples of anomalies are available, making it ideal for online anomaly detection, active learning, and highly unbalanced datasets. Besides, DRAMA naturally provides clustering of outliers for subsequent analysis.
Collapse
Affiliation(s)
- Alireza Vafaei Sadr
- Département de Physique Théorique and Center for Astroparticle Physics, University of Geneva, Geneva, Switzerland
- Institute for Research in Fundamental Sciences (IPM), P. O. Box 19395-5531, Tehran, Iran
- African Institute for Mathematical Sciences, Cape Town, South Africa
| | - Bruce A. Bassett
- African Institute for Mathematical Sciences, Cape Town, South Africa
- South African Radio Astronomy Observatory, University of Cape Town, Cape Town, 7925 South Africa
- Mathematics Department, University of Cape Town, Cape Town, 7700 South Africa
| | - M. Kunz
- Département de Physique Théorique and Center for Astroparticle Physics, University of Geneva, Geneva, Switzerland
| |
Collapse
|
4
|
Amruthalingam L, Mang N, Gottfrois P, Jimenez AG, Maul J, Kunz M, Pouly M, Navarini A. 143 Automated Anatomical Mapping of Hand Eczema. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.09.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
5
|
Amruthalingam L, Gottfrois P, Gonzalez Jimenez A, Gökduman B, Kunz M, Koller T, Pouly M, Navarini A. Improved diagnosis by automated macro- and micro-anatomical region mapping of skin photographs. J Eur Acad Dermatol Venereol 2022; 36:2525-2532. [PMID: 35924423 PMCID: PMC9804282 DOI: 10.1111/jdv.18476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2022] [Accepted: 06/30/2022] [Indexed: 01/05/2023]
Abstract
BACKGROUND The exact location of skin lesions is key in clinical dermatology. On one hand, it supports differential diagnosis (DD) since most skin conditions have specific predilection sites. On the other hand, location matters for dermatosurgical interventions. In practice, lesion evaluation is not well standardized and anatomical descriptions vary or lack altogether. Automated determination of anatomical location could benefit both situations. OBJECTIVE Establish an automated method to determine anatomical regions in clinical patient pictures and evaluate the gain in DD performance of a deep learning model (DLM) when trained with lesion locations and images. METHODS Retrospective study based on three datasets: macro-anatomy for the main body regions with 6000 patient pictures partially labelled by a student, micro-anatomy for the ear region with 182 pictures labelled by a student and DD with 3347 pictures of 16 diseases determined by dermatologists in clinical settings. For each dataset, a DLM was trained and evaluated on an independent test set. The primary outcome measures were the precision and sensitivity with 95% CI. For DD, we compared the performance of a DLM trained with lesion pictures only with a DLM trained with both pictures and locations. RESULTS The average precision and sensitivity were 85% (CI 84-86), 84% (CI 83-85) for macro-anatomy, 81% (CI 80-83), 80% (CI 77-83) for micro-anatomy and 82% (CI 78-85), 81% (CI 77-84) for DD. We observed an improvement in DD performance of 6% (McNemar test P-value 0.0009) for both average precision and sensitivity when training with both lesion pictures and locations. CONCLUSION Including location can be beneficial for DD DLM performance. The proposed method can generate body region maps from patient pictures and even reach surgery relevant anatomical precision, e.g. the ear region. Our method enables automated search of large clinical databases and make targeted anatomical image retrieval possible.
Collapse
Affiliation(s)
- L. Amruthalingam
- Department of Biomedical EngineeringUniversity of BaselBaselSwitzerland,Lucerne School of Computer Science and Information TechnologyLucerne University of Applied Sciences and ArtsLucerneSwitzerland
| | - P. Gottfrois
- Department of Biomedical EngineeringUniversity of BaselBaselSwitzerland
| | | | - B. Gökduman
- Lucerne School of Computer Science and Information TechnologyLucerne University of Applied Sciences and ArtsLucerneSwitzerland
| | - M. Kunz
- Department of Health Sciences and TechnologySwiss Federal Institute of TechnologyZurichSwitzerland
| | - T. Koller
- Department of DermatologyUniversity Hospital of BaselBaselSwitzerland
| | | | - M. Pouly
- Department of DermatologyUniversity Hospital of BaselBaselSwitzerland
| | - A.A. Navarini
- Department of Health Sciences and TechnologySwiss Federal Institute of TechnologyZurichSwitzerland
| |
Collapse
|
6
|
Mueller A, Gössinger E, Kostner L, Amaral M, Huber S, Kunz M, Navarini A, Maul L. 491 Education level is associated with increased sun exposure, but also ultraviolet radiation protection and melanoma awareness in a high-risk population in Switzerland. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.09.505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
7
|
Reicherts P, Zerbini G, Halms T, Strasser M, Papazova I, Hasan A, Kunz M. COVID-19 related psychological burden and potential benefits of vaccination - Data from a repeated cross-sectional survey in healthcare workers. Psychiatry Research Communications 2022; 2:100054. [PMID: 35702354 PMCID: PMC9181270 DOI: 10.1016/j.psycom.2022.100054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/21/2022] [Revised: 05/13/2022] [Accepted: 06/05/2022] [Indexed: 11/27/2022]
Abstract
The COVID-19 pandemic is impacting the psychological well-being, especially of health care workers, for more than two years now. Here, we followed-up on a survey we conducted at the very beginning of the pandemic, to determine potential changes in psychological strain experienced by health care workers one year later. Since our first survey in 2020, COVID-19 vaccines have been established, thus we assessed whether vaccination-status might modulate psychological burden of health care workers. We also collected data on resilience and sleep, as those might be related to successful coping. Between March and April 2021, nurses and physicians (N = 286) working at the University Hospital Augsburg - with high or low exposure to COVID-19 patients - took part in an online survey. We found that fully vaccinated personnel reported lower levels of anxiety, depression, stress and exhaustion suggesting the potential positive consequences of vaccination beyond the obvious protection against a COVID-19 infection. Nurses reported more depressive symptoms, anxiety, stress and exhaustion and lower levels of job fulfilment than physicians. Individuals with high exposure to COVID-19 patients reported higher exhaustion and depersonalization. Resilience and sleep quality were significantly correlated with psychological and work-related burden, suggesting their potential role as protective resources. In general, the comparison of the present data to the survey conducted in 2020 suggests an overall increase of psychological burden in health care workers. Despite these surely alarming findings, it should be noted that being vaccinated might come along with reduced psychological strain.
Collapse
Affiliation(s)
- P Reicherts
- Department of Medical Psychology and Sociology, Medical Faculty, University of Augsburg, Germany
| | - G Zerbini
- Department of Medical Psychology and Sociology, Medical Faculty, University of Augsburg, Germany
| | - T Halms
- Department of Medical Psychology and Sociology, Medical Faculty, University of Augsburg, Germany
- Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, Bezirkskrankenhaus, Augsburg, Germany
| | - M Strasser
- Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, Bezirkskrankenhaus, Augsburg, Germany
| | - I Papazova
- Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, Bezirkskrankenhaus, Augsburg, Germany
| | - A Hasan
- Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, University of Augsburg, Bezirkskrankenhaus, Augsburg, Germany
| | - M Kunz
- Department of Medical Psychology and Sociology, Medical Faculty, University of Augsburg, Germany
| |
Collapse
|
8
|
Cao S, Song R, Meng X, Kachler K, Fuchs M, Meng X, Li Y, Taudte V, Kunz M, Schloetzer-Schrehardt U, Schleicher U, Chen X, Schett G, Bozec A. OP0076 L-ARGININE REPROGRAMS OSTEOCLAST PURINE METABOLISM AMELIORATING BONE LOSS IN RHEUMATOID ARTHRITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.4338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundBone erosion is a clinical feature of rheumatoid arthritis related to disease severity and poor functional prognosis. Excessive osteoclast differentiation and insufficient osteoblast function are the main reasons for the erosive process in RA. Our previous investigation indicated that L-arginine supplementation not only diminished arthritic inflammation in the serum-induced arthritis (K/BxN) model but also decreased inflammatory joints osteoclast numbers (1).ObjectivesIn the present study, we aim to investigate the metabolic action of L-arginine supplementation in RA, especially on periarticular bone erosion and systemic bone loss. We plan to depict the metabolic features of TNFα induced inflammatory osteoclasts after in vitro L-arginine supplementation.MethodsThree murine arthritis models (serum-induced arthritis (K/BxN) model, collagen-induced arthritis model, and hTNFtg mice model) were analysed in this study. L-arginine was supplemented within the drinking water after the onset of arthritis. Bone parameters for axial skeleton (spine) and peripheral skeleton (tibia) from the respective group were quantified by μCT. HE and TRAP staining were performed to address further the erosion area and osteoclast numbers in periarticular sites. In vitro osteoclast differentiation was conducted with or without L-arginine treatment, in the presence or not of TNFα activation. Seahorse and SCENITH analyses were adopted to delineate the metabolic features. JC-1 staining and transmission electron microscopy (TEM) were used to depict the mitochondria metabolism. RNA-seq and mass spectrometry (MS) were performed to investigate the underlying molecular mechanism.ResultsInflammation was diminished in all three arthritis models after L-arginine supplementation with a significant reduction in arthritic score. Moreover, an amelioration of periarticular bone erosion, systemic bone loss, and decreased osteoclast numbers in periarticular sites were observed in arthritic mice after L-arginine treatment. L-arginine also inhibited osteoclastogenesis in vitro, particularly under TNFα activation. Seahorse and SCENITH analyses indicated TNFα promoted glycolysis while blocking mitochondria-driven oxidative phosphorylations (OXPHOS) in pre-osteoclasts. Meanwhile, JC-1 staining and TEM images also showed that TNFα decreased mitochondria membrane potential and prompted damage of mitochondria. Surprisingly, L-arginine rescued the TNFα inhibition of OXPHOS while promoting ATP production.RNA-seq and MS data confirmed the boost of OXPHOS after L-arginine treatment under TNFα activation. To interfere with OXPHOS, L-arginine inhibited cJun thus altered arginase-1 and arginase-2 expression. Moreover, the increased ATP in L-arginine treated cells facilitated purine metabolism, especially the production of inosine and hypoxanthine, contributing to the inhibition of osteoclastogenesis. Increasing Adenosine deaminase (ADA) is essential for the production of inosine and hypoxanthine due to the decreased inhibitory regulation of the transcription factor c-Jun.ConclusionThese data strongly demonstrated that L-arginine ameliorates bone erosion in RA through metabolic reprogramming and perturbation of purine metabolism in osteoclasts. L-arginine might therefore benefit RA therapy by reducing joint inflammation and also ameliorating bone destruction.References[1]Hannemann, Nicole, et al. “Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis.” The Journal of clinical investigation 129.7 (2019): 2669-2684.Disclosure of InterestsShan Cao: None declared, Rui Song: None declared, Xianyi Meng: None declared, Katerina Kachler: None declared, Maximilian Fuchs: None declared, Xinyu Meng: None declared, Yixuan Li: None declared, Verena Taudte: None declared, Meik Kunz: None declared, Ursula Schloetzer-Schrehardt: None declared, Ulrike Schleicher: None declared, Xiaoxiang Chen Speakers bureau: AbbVie, Roche and Novartis, Georg Schett Speakers bureau: AbbVie, BMS, Celgene, Janssen, Eli Lilly, Novartis, Roche and UCB, Aline Bozec: None declared.
Collapse
|
9
|
Pontones M, Höfener H, Kock F, Schwen L, Westphal M, Dickel N, Kunz M, Metzler M. Comprehensive bone marrow analysis integrating deep learning-based
pattern discovery (BMDeep). KLINISCHE PADIATRIE 2022. [DOI: 10.1055/s-0042-1748749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
| | | | - F Kock
- Fraunhofer MEVIS, Germany
| | | | | | | | | | - M Metzler
- Universitätsklinikum Erlangen, Germany
| |
Collapse
|
10
|
Böhler L, Dumann K, Kunz M. Symmetrical pruritic lesions on the trunk in a young woman – a rare case of non‐associated Prurigo pigmentosa in Germany. J Eur Acad Dermatol Venereol 2022; 36:e648-e650. [PMID: 35349741 DOI: 10.1111/jdv.18113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Accepted: 03/23/2022] [Indexed: 12/01/2022]
Affiliation(s)
- L Böhler
- Department of Dermatology University Hospital Leipzig Germany
| | - K Dumann
- Department of Dermatology University Hospital Leipzig Germany
| | - M Kunz
- Department of Dermatology University Hospital Leipzig Germany
| |
Collapse
|
11
|
Poyet C, Scherer T, Kunz M, Kaufmann B, Eberli D, Rogmann S, Hermanns T. Large varieties in the use and uptake of active surveillance for low risk prostate cancer between an academic center and the remaining urology community in the canton of Zurich, Switzerland. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00357-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Dees C, Poetter S, Fuchs M, Bergmann C, Matei AE, Györfi AH, Soare A, Ramming A, Ceppi P, Schett G, Kunz M, Distler JHW. POS0423 NCOA3 AMPLIFIES PROFIBROTIC TRANSCRIPTIONAL PROGRAMS IN SYSTEMIC SCLEROSIS. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.1106] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Excessive activation of fibroblasts with a TGFβ-biased gene signature and deposition of extracellular matrix are key features of fibrotic diseases. The mechanisms underlying these transcriptional changes remain poorly understood. Deregulation, mutations and malfunctions of transcriptional co-regulators, which can interact with multiple transcription factors and enable a broad-spectrum regulation of transcriptional networks, have been implicated as driving factors in a large number of diseases and pathologies.Objectives:In the present study, we aimed to analyze the role of the co-regulator Nuclear Receptor Co-Activator 3 (NCOA3) in fibroblast activation and tissue fibrosis, and to evaluate a potential interaction of NCOA3 with fibrosis-relevant transcription factors.Methods:NCOA3 was inhibited genetically by siRNA transfection and pharmacologically by the SRC3 inhibitor-2 (SI-2). We performed bulk RNASeq of human dermal fibroblasts and in silico transcription factor binding site screening of differentially expressed genes (DEGs). The interaction of NCOA3 and TGFβ-SMAD signaling was analyzed by reporter and CoIP assays.Results:The expression of NCOA3 in skin biopsies of SSc patients compared to normal controls demonstrated that SSc fibroblasts express modestly, but significantly reduced levels of NCOA3, which persisted in cultured SSc fibroblasts. Stimulation of normal fibroblasts with chronically high levels of TGFβ as they also occur in fibrotic tissue remodeling strongly decreased NCOA3 expression to a similar extent as in SSc fibroblasts. Furthermore, NCOA3 expression is also deregulated in different murine models of skin fibrosis. To investigate the functional effects of decreased NCOA3 levels, we targeted the expression of NCOA3 in normal fibroblasts. SiRNA-mediated knockdown of NCOA3 ameliorated TGFβ-induced gene expression, collagen release, myofibroblast differentiation and cell proliferation. In contrast, knockdown of NCOA3 had no effects on collagen release, expression of contractile proteins or gene expression in unstimulated fibroblasts, suggesting that NCOA3 is not required for cellular homeostasis. To characterize the molecular mechanisms, we performed RNASeq upon NCOA3 knockdown. We identified 343 significant differentially expressed genes (220 downregulated and 123 upregulated with a Benjamini-Hochberg false discovery rate FDR < 0.25 and fold change > 1.5) between TGFβ-stimulated fibroblasts with and without NCOA3 knockdown (NCOA3-DEGs) including the fibrosis-relevant genes EDNRB, COL5A3, HES1, IL11 or IL33. Functional analysis of the NCOA3-DEGs showed enrichment of pathway terms such as collagen binding and extracellular matrix organization. In silico screening of the promoters of the NCOA3-DEGs for potential transcription factor binding motifs revealed binding motifs of core transcription factors of fibroblast activation and tissue fibrosis such as SMAD2/3/4, RBPJ, ZEB1, TCF4, REL, and SNAIL2 amongst the downregulated NCOA3-DEGs. Experimental validation of our biostatistical results using SMAD3 as example demonstrated a higher percentage of NCOA3-pSMAD3 double-positive fibroblasts in skin sections of SSc patients compared to healthy controls. In addition, knockdown of NCOA3 reduced TGFβ-induced SMAD-reporter activity. Furthermore, stimulation with TGFβ increased the interaction of NCOA3 with SMAD3 as analyzed by co-immunoprecipitation. Simultaneous knockdown of NCOA3 and SMAD3 showed no additional reductions compared to the single knockdowns, suggesting that NCOA3 controls SMAD3-dependent gene transcription under fibrotic conditions. Finally, inhibition of NCOA3 showed anti-fibrotic effects in different murine models of experimental skin and lung fibrosis.Conclusion:Our findings characterize NCOA3 as regulator of multiple pro-fibrotic transcription programs. Pharmaceutical inhibition of NCOA3 might be a strategy to interfere simultaneously with several core pro-fibrotic mediators in fibrotic diseases such as SSc.Acknowledgements:We thank Lena Summa, Vladyslav Fedorchenko, Wolfgang Espach and Regina Kleinlein for excellent technical assistance.The study was funded by grants DI 1537/7-1, DI 1537/8-1, DI 1537/9-1 and -2, DI 1537/11-1, DI 1537/12-1, DI 1537/13-1, DI 1537/14-1, DI 1537/17-1, DE 2414/2-1, DE 2414/4-1, and RA 2506/3-1 of the German Research Foundation, SFB CRC1181 (project C01) and SFB TR221/ project number 324392634 (B04) of the German Research Foundation, grants J39, J40 and A64 of the IZKF in Erlangen, grant 2013.056.1 of the Wilhelm-Sander-Foundation, grants 2014_A47, 2014_A248 and 2014_A184 of the Else-Kröner-Fresenius-Foundation, grant 14-12-17-1-Bergmann of the ELAN-Foundation Erlangen, BMBF (Era-Net grant 01KT1801), MASCARA program, TP 2 and a Career Support Award of Medicine of the Ernst Jung Foundation.Disclosure of Interests:Clara Dees: None declared, Sebastian Poetter: None declared, Maximilian Fuchs: None declared, Christina Bergmann: None declared, Alexandru-Emil Matei: None declared, Andrea-Hermina Györfi: None declared, Alina Soare: None declared, Andreas Ramming: None declared, Paolo Ceppi: None declared, Georg Schett: None declared, Meik Kunz: None declared, Jörg H.W. Distler Consultant of: Actelion, Active Biotech, Anamar, ARXX, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, JB Therapeutics, Medac, Pfizer, RuiYi and UCB, Grant/research support from: Anamar, Active Biotech, Array Biopharma, ARXX, aTyr, BMS, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, Novartis, Sanofi-Aventis, RedX, UCB
Collapse
|
13
|
|
14
|
Györfi AH, Matei AE, Fuchs M, Rius Rigau A, Hong X, Honglin Z, Luber M, Bergmann C, Dees C, Ludolph I, Horch R, Distler O, Schett G, Kunz M, Distler JHW. POS0328 ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.1428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Engrailed 1 (EN1) is a homeodomain-containing transcription factor with essential roles in embryonic development. In most cell types, the expression of EN1 is restricted to embryonic development. However, under pathological conditions, EN1 can be re-expressed to promote phenotypical adaptation. En1 is transiently expressed in the developing dermis of murine embryos in a distinct fibroblast lineage and silenced before birth (1). Former EN1-expressing cells give rise to a subpopulation of fibroblasts that has a high capacity for extracellular matrix production in adult murine skin. The role of EN1 in systemic sclerosis (SSc) was previously not explored.Objectives:To study the role of EN1 in the pathological activation of fibroblasts in tissue fibrosis.Methods:Bulk RNA-Seq and EN1 or SP1 ChIP-Seq were performed from cultured human dermal fibroblasts. The expression of EN1 was inhibited by siRNA. Cytoskeletal drugs paclitaxel, vinblastin and ROCK inhibitor (Y27632) were used to modulate the cytoskeleton in EN1 knockdown or overexpressing dermal fibroblasts. The role of EN1 in fibroblast activation was evaluated by functional experiments with EN1 knockdown or overexpression in standard 2D culture systems as well as in 3D skin equivalent models. The role of EN1 in skin fibrosis was further studied in En1fl/fl X Col6Cre mice, with fibroblast-specific knockout of En1 in three complementary mouse models: overexpression of a constitutively active TGFß-receptor I (TBRICA), bleomycin-induced skin fibrosis and TSK1 mice.Results:Pathologically activated dermal fibroblasts from SSc patients express higher levels of EN1 compared with age and sex matched healthy individuals in the skin and in vitro. TGFβ induces EN1 expression in fibroblasts in a SMAD3-dependent manner both in cultured fibroblasts and in murine skin. Knockdown of EN1 prevents TGFβ-induced fibroblast activation, whereas overexpression of EN1 fosters the pro-fibrotic effects of TGFβ with increased expression of αSMA, stress fibers and collagen. RNA sequencing demonstrates that EN1 induces a pro-fibrotic gene expression profile functionally related to cytoskeleton organization and ROCK activation. In silico analyses of the promoters of En1 target genes coupled with siRNA-mediated knockdown demonstrated that EN1 regulates these pro-fibrotic target genes by modulating the activity of regulatory modules that contain transcription factors of the specificity protein (SP) family. Functional experiments with selective modulators of ROCK and of microtubule polymerization confirm the coordinating role of EN1 on ROCK activity and the re-organization of cytoskeleton during myofibroblast differentiation in both conventional culture systems and 3D skin equivalents. Consistently, mice with fibroblast-specific knockout of En1 demonstrate impaired fibroblast-to-myofibroblast transition, reduced dermal thickening and impaired collagen deposition in the TBRICA, bleomycin-induced and TSK1 models.Conclusion:We characterize the homeodomain transcription factor EN1 as a molecular amplifier of TGFβ signaling in myofibroblast differentiation that coordinates cytoskeletal organization in a SP-dependent manner. EN1 might thus be a novel candidate for molecular targeted therapies to interfere with myofibroblast differentiation in fibrotic diseases.References:[1]Rinkevich Y, Walmsley GG, Hu MS, Maan ZN, Newman AM, Drukker M, et al. Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science. 2015;348(6232):aaa2151.Disclosure of Interests:Andrea-Hermina Györfi: None declared, Alexandru-Emil Matei: None declared, Maximilian Fuchs: None declared, Aleix Rius Rigau: None declared, Xuezhi Hong: None declared, ZHU Honglin: None declared, Markus Luber: None declared, Christina Bergmann: None declared, Clara Dees: None declared, Ingo Ludolph: None declared, Raymund Horch: None declared, Oliver Distler Consultant of: Actellion, AbbVie, Acceleron Pharma, Anamar, Amgen, Blade Therapeutics, CSL Behring, ChemomAb, Ergonex, Glenmark Pharma, GSK, Inventiva, Italfarmaco, iQvia, Medac, Medscape, Lilly, Sanofi, Target BioScience, UCB, Bayer, Boehringer Ingelheim, Catenion, iQone, Menarini, Mepha, Novartis, Mitsubishi, MSD, Roche, Pfizer, Georg Schett: None declared, Meik Kunz: None declared, Jörg H.W. Distler Consultant of: Actelion, Active Biotech, Anamar, ARXX, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, JB Therapeutics, Medac, Pfizer, RuiYi and UCB., Grant/research support from: Anamar, Active Biotech, Array Biopharma, aTyr, BMS, Bayer Pharma, Boehringer Ingelheim, Celgene, Galapagos, GSK, Inventiva, Novartis, Sanofi-Aventis, RedX, UCB
Collapse
|
15
|
Rabelo-da-Ponte FD, Feiten JG, Mwangi B, Barros FC, Wehrmeister FC, Menezes AM, Kapczinski F, Passos IC, Kunz M. Early identification of bipolar disorder among young adults - a 22-year community birth cohort. Acta Psychiatr Scand 2020; 142:476-485. [PMID: 32936930 DOI: 10.1111/acps.13233] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 09/06/2020] [Indexed: 12/25/2022]
Abstract
OBJECTIVE We set forth to build a prediction model of individuals who would develop bipolar disorder (BD) using machine learning techniques in a large birth cohort. METHODS A total of 3748 subjects were studied at birth, 11, 15, 18, and 22 years of age in a community birth cohort. We used the elastic net algorithm with 10-fold cross-validation to predict which individuals would develop BD at endpoint (22 years) at each follow-up visit before diagnosis (from birth up to 18 years). Afterward, we used the best model to calculate the subgroups of subjects at higher and lower risk of developing BD and analyzed the clinical differences among them. RESULTS A total of 107 (2.8%) individuals within the cohort presented with BD type I, 26 (0.6%) with BD type II, and 87 (2.3%) with BD not otherwise specified. Frequency of female individuals was 58.82% (n = 150) in the BD sample and 53.02% (n = 1868) among the unaffected population. The model with variables assessed at the 18-year follow-up visit achieved the best performance: AUC 0.82 (CI 0.75-0.88), balanced accuracy 0.75, sensitivity 0.72, and specificity 0.77. The most important variables to detect BD at the 18-year follow-up visit were suicide risk, generalized anxiety disorder, parental physical abuse, and financial problems. Additionally, the high-risk subgroup of BD showed a high frequency of drug use and depressive symptoms. CONCLUSIONS We developed a risk calculator for BD incorporating both demographic and clinical variables from a 22-year birth cohort. Our findings support previous studies in high-risk samples showing the significance of suicide risk and generalized anxiety disorder prior to the onset of BD, and highlight the role of social factors and adverse life events.
Collapse
Affiliation(s)
- F D Rabelo-da-Ponte
- Molecular Psychiatry Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.,Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.,National Institute for Translational Medicine (INCT-TM), Porto Alegre, Brazil
| | - J G Feiten
- Molecular Psychiatry Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.,Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.,National Institute for Translational Medicine (INCT-TM), Porto Alegre, Brazil
| | - B Mwangi
- Department of Psychiatry & Behavioral Sciences, UT Center of Excellence on Mood Disorders, The University of Texas Health Science Center at Houston, Houston, TX, USA
| | - F C Barros
- Graduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil
| | - F C Wehrmeister
- Graduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil
| | - A M Menezes
- Graduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Brazil
| | - F Kapczinski
- National Institute for Translational Medicine (INCT-TM), Porto Alegre, Brazil.,Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
| | - I C Passos
- Molecular Psychiatry Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.,Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.,National Institute for Translational Medicine (INCT-TM), Porto Alegre, Brazil
| | - M Kunz
- Molecular Psychiatry Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.,Graduate Program in Psychiatry and Behavioral Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.,National Institute for Translational Medicine (INCT-TM), Porto Alegre, Brazil
| |
Collapse
|
16
|
Feuchter S, Kunz M, Djamei V, Navarini AA. Anonymous automated counselling for aesthetic dermatology using a chatbot - an analysis of age- and gender-specific usage patterns. J Eur Acad Dermatol Venereol 2020; 35:e194-e195. [PMID: 32869372 DOI: 10.1111/jdv.16907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S Feuchter
- Faculty of Medicine, University of Zurich, Zurich, Switzerland
| | - M Kunz
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| | - V Djamei
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
| | - A A Navarini
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland
| |
Collapse
|
17
|
Mohamed S, Kunz M, Casey S, Katsiyiannis W, Abdelhadi R, Storey K, Berg A, Schmidt C, Sengupta J. P1077Late gadolinium enhancement with cardiac magnetic resonance imaging demonstrates left ventricular involvement is under-recognized in arrhythmogenic right ventricular cardiomyopathy. Europace 2020. [DOI: 10.1093/europace/euaa162.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
The study is partially funded by Medtronic and the Minneapolis Heart Institute Foundation.
Background/Introduction: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by replacement of the myocardium with fibrous and fatty tissue that may lead to an increased risk of ventricular arrhythmias and heart failure. Although left ventricular (LV) and biventricular forms have been identified post-mortem resulting in the increased use of the term arrhythmogenic cardiomyopathy, there is only inclusion of right ventricular wall motion abnormalities in the taskforce diagnostic criteria.
Purpose
The aim of our study was to examine the utility of cardiac magnetic resonance (CMR) imaging in characterizing LV or biventricular involvement with late gadolinium enhancement (LGE) in a large cohort of patients with suspected ARVC.
Methods
Retrospective, single-institution, chart review of 76 patients diagnosed with ARVC between January 2009 and July 2019. Data collection and analysis included baseline demographics and parameters specific to diagnosis (definite, borderline, or possible) and risk stratification of ARVC based on 2019 modified taskforce criteria, as well as detailed CMR evaluation.
Results
Of the 76 patients with ARVC, 66 (87%) had at least one CMR with gadolinium administered. In that subset of patients, 27 (41%) had LGE. Of those with LGE, LV involvement was identified in 23 (85%) patients. The pattern of LGE was not localized to one myocardial region but demonstrated variable LV enhancement patterns including anterior, inferior, lateral, septal, basal, mid, apical, and from the sub-epicardium into the mid-myocardium.
Conclusions
Left ventricular involvement reflected by LGE was identified in a high percentage of patients with suspected ARVC, and there was significant variation in the pattern of distribution in terms of region and depth of myocardial involvement. While post-mortem examination of patients with ARVC demonstrates a high prevalence of left ventricular involvement, this study shows that CMR can consistently detect late gadolinium enhancement, and ARVC should be considered in the differential diagnosis for biventricular cardiomyopathy. The identification of variable locations of LGE within the LV suggests there is more than one phenotype, and this imaging modality may help to clarify the implications of left ventricular involvement in disease progression.
Collapse
Affiliation(s)
- S Mohamed
- Minneapolis Heart Institute Foundation, Minneapolis, United States of America
| | - M Kunz
- Minneapolis Heart Institute Foundation, Minneapolis, United States of America
| | - S Casey
- Minneapolis Heart Institute Foundation, Minneapolis, United States of America
| | - W Katsiyiannis
- Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, United States of America
| | - R Abdelhadi
- Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, United States of America
| | - K Storey
- Minneapolis Heart Institute Foundation, Minneapolis, United States of America
| | - A Berg
- Children"s Minnesota, Minneapolis, United States of America
| | - C Schmidt
- Minneapolis Heart Institute Foundation, Minneapolis, United States of America
| | - J Sengupta
- Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, United States of America
| |
Collapse
|
18
|
Markovic A, Simon JC, Kirsten HL, Kunz M. Schmerzhafte artifizielle Ekchymosen an Hals und Gesicht. Aktuelle Dermatologie 2020. [DOI: 10.1055/a-1030-9425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
ZusammenfassungEs wird über den Fall einer 13-jährigen Patientin mit neu aufgetretenen, auf Druck schmerzhaften Hautveränderungen beidseits am Hals und im Gesicht berichtet. Auf Nachfrage traten die Effloreszenzen episodisch im Rahmen von Stresssituationen auf. Im Verlauf kam es zu einer Spontanheilung mit Narbenbildung und mehreren Rezidiven. Nach erfolgter Probebiopsie wurde ein Gardner-Diamond-Syndrom ausgeschlossen und der Verdacht auf selbstinduzierte Hautläsionen geäußert.
Collapse
Affiliation(s)
- A. Markovic
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Leipzig
| | - J. C. Simon
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Leipzig
| | - H. L. Kirsten
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Leipzig
| | - M. Kunz
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Leipzig
| |
Collapse
|
19
|
Bauer M, Glenn T, Alda M, Andreassen O, Angelopoulos E, Ardau R, Baethge C, Bauer R, Bellivier F, Belmaker R, Berk M, Bjella T, Bossini L, Bersudsky Y, Cheung E, Conell J, Del Zompo M, Dodd S, Etain B, Fagiolini A, Frye M, Fountoulakis K, Garneau-Fournier J, Gonzalez-Pinto A, Harima H, Hassel S, Henry C, Iacovides A, Isometsä E, Kapczinski F, Kliwicki S, König B, Krogh R, Kunz M, Lafer B, Larsen E, Lewitzka U, Lopez-Jaramillo C, MacQueen G, Manchia M, Marsh W, Martinez-Cengotitabengoa M, Melle I, Monteith S, Morken G, Munoz R, Nery F, O’Donovan C, Osher Y, Pfennig A, Quiroz D, Ramesar R, Rasgon N, Reif A, Ritter P, Rybakowski J, Sagduyu K, Scippa A, Severus E, Simhandl C, Stein D, Strejilevich S, Hatim Sulaiman A, Suominen K, Tagata H, Tatebayashi Y, Torrent C, Vieta E, Viswanath B, Wanchoo M, Zetin M, Whybrow P. Influence of birth cohort on age of onset cluster analysis in bipolar I disorder. Eur Psychiatry 2020; 30:99-105. [DOI: 10.1016/j.eurpsy.2014.10.005] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/02/2014] [Revised: 09/10/2014] [Accepted: 10/21/2014] [Indexed: 10/24/2022] Open
Abstract
AbstractPurpose:Two common approaches to identify subgroups of patients with bipolar disorder are clustering methodology (mixture analysis) based on the age of onset, and a birth cohort analysis. This study investigates if a birth cohort effect will influence the results of clustering on the age of onset, using a large, international database.Methods:The database includes 4037 patients with a diagnosis of bipolar I disorder, previously collected at 36 collection sites in 23 countries. Generalized estimating equations (GEE) were used to adjust the data for country median age, and in some models, birth cohort. Model-based clustering (mixture analysis) was then performed on the age of onset data using the residuals. Clinical variables in subgroups were compared.Results:There was a strong birth cohort effect. Without adjusting for the birth cohort, three subgroups were found by clustering. After adjusting for the birth cohort or when considering only those born after 1959, two subgroups were found. With results of either two or three subgroups, the youngest subgroup was more likely to have a family history of mood disorders and a first episode with depressed polarity. However, without adjusting for birth cohort (three subgroups), family history and polarity of the first episode could not be distinguished between the middle and oldest subgroups.Conclusion:These results using international data confirm prior findings using single country data, that there are subgroups of bipolar I disorder based on the age of onset, and that there is a birth cohort effect. Including the birth cohort adjustment altered the number and characteristics of subgroups detected when clustering by age of onset. Further investigation is needed to determine if combining both approaches will identify subgroups that are more useful for research.
Collapse
|
20
|
Lehner M, Wendling-Keim D, Kunz M, Deininger S, Zundel S, Peraud A, Mast G. On-site CAD templates reduce surgery time for complex craniostenosis repair in infants: a new method. Childs Nerv Syst 2020; 36:793-801. [PMID: 31900627 DOI: 10.1007/s00381-019-04474-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/28/2019] [Accepted: 12/10/2019] [Indexed: 10/25/2022]
Abstract
INTRODUCTION The surgical correction of craniostenosis in children is a time-consuming and taxing procedure. To facilitate this procedure, especially in infants with complex craniostenosis, we refined the computer-aided design and manufacturing technique (CAD/CAM) based on computed tomography (CT)-generated DICOM data. We used cutting guides and molding templates, which allowed the surgeon to reshape and fixate the supraorbital bar extracorporeally on a side table and to control the intracorporal fit without removing the template. METHOD AND PATIENTS To compare our traditional concept with the possibility of preoperative virtual planning (PVP) technique, the surgical treatment and courses of 16 infants with complex craniostenosis following fronto-orbital advancement (FOA) (age range 8-15 months) were analyzed in two groups (group 1: traditional, control group n = 8, group 2: CAD/CAM planned, n = 8). RESULTS While in both groups, the head accurately reshaped postoperatively during the follow-up; the CAD group 2 showed a significantly shorter operating time with a mean of 4 h 25 min compared with group 1 with a mean of 5 h 37 min (p = 0.038). Additionally, the CAD group 2 had a significantly lower volume of blood loss (380 ml vs. 575 ml mean, p = 0.047), lower blood transfusion volume (285 ml vs. 400 ml mean, p = 0.108), lower fresh frozen plasma (FFP) volume (140 ml vs. 275 ml mean, p = 0.019), shorter stay in the pediatric intensive care unit (PICU) (3 vs. 5 days mean (p = 0.002), and shorter total length of hospital stay (6 days vs. 8 days mean, p = 0.002). CONCLUSION CAD/CAM cutting guides and templates offer optimizing operative efficiency, precision, and accuracy in craniostenosis surgery in infants. As shown in this single-center observational study, the use of on-site templates significantly accelerates the reconstruction of the bandeau. The virtual 3D planning technique increases surgical precision without discernible detrimental effects.
Collapse
Affiliation(s)
- Markus Lehner
- Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany. .,Department of Pediatric Surgery, Children's Hospital of Lucerne, Kantonsspital Lucerne, Lucerne, Switzerland.
| | - D Wendling-Keim
- Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University of Munich, Munich, Germany
| | - M Kunz
- Department of Neurosurgery, Ludwig-Maximilians-University of Munich, Munich, Germany
| | - S Deininger
- Department of Pediatric Surgery, Children's Hospital of Lucerne, Kantonsspital Lucerne, Lucerne, Switzerland.,Department of Neurosurgery, Section Pediatric Neurosurgery, University of Ulm, Ulm, Germany
| | - S Zundel
- Department of Pediatric Surgery, Children's Hospital of Lucerne, Kantonsspital Lucerne, Lucerne, Switzerland
| | - A Peraud
- Department of Neurosurgery, Ludwig-Maximilians-University of Munich, Munich, Germany.,Department of Neurosurgery, Section Pediatric Neurosurgery, University of Ulm, Ulm, Germany
| | - G Mast
- Department of Orofacial Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany
| |
Collapse
|
21
|
Kunz M, Gorges M, Liepelt-Scarfone I, Storch A, Dodel R, Consortium L, Hilker-Roggendorf R, Berg D, Kalbe E, Müller H, Baudrexel S, Kassubek J. FV4 Brain atrophy distribution and rate of change in patients with advanced Parkinsons disease and cognitive impairment. Clin Neurophysiol 2020. [DOI: 10.1016/j.clinph.2019.12.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
22
|
Lautenbacher S, Kunz M. [Assessing pain in patients with dementia]. Anaesthesist 2019; 68:814-820. [PMID: 31701173 DOI: 10.1007/s00101-019-00683-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
The diagnostics of pain in older people with cognitive impairments should always consist of a subjective self-report of pain and a structured observation of pain behavior. It is important to note that the subjective self-report of pain becomes less valid with increasing cognitive decline (starting with a moderate degree of dementia). The external observation of pain behavior should include at least the three behavioral domains facial expressions, body movements and vocalization and should be performed during resting situations and during activities of daily living. Moreover, the patient should be observed for at least 3 min. Online forms of training have recently been developed and are freely available for training in external observation.
Collapse
Affiliation(s)
- S Lautenbacher
- Physiologische Psychologie, Universität Bamberg, Markusplatz 3, 96045, Bamberg, Deutschland.
| | - M Kunz
- Medizinische Psychologie und Soziologie, Medizinische Fakultät, Universität Augsburg, Augsburg, Deutschland
| |
Collapse
|
23
|
Spänig S, Kirchberg J, Simon J, Magin T, Kunz M. 443 Mechanisms of Keratinocyte-Melanoma Cell Interaction. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
24
|
Gorges M, Schmidt D, Kunz M, Knehr A, Lule D, Pinkhardt E, Weishaupt J, Ludolph A, Kassubek J. FV 29 Executive eye movement impairment in presymptomatic amyotrophic lateral sclerosis mutation carriers. Clin Neurophysiol 2019. [DOI: 10.1016/j.clinph.2019.04.638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
25
|
Weissenstein U, Kunz M, Oufir M, Wang JT, Hamburger M, Urech K, Regueiro U, Baumgartner S. Absence of herb-drug interactions of mistletoe with the tamoxifen metabolite (E/Z)-endoxifen and cytochrome P450 3A4/5 and 2D6 in vitro. BMC Complement Altern Med 2019; 19:23. [PMID: 30658716 PMCID: PMC6339413 DOI: 10.1186/s12906-019-2439-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/09/2018] [Accepted: 01/14/2019] [Indexed: 01/16/2023]
Abstract
Background Women diagnosed with breast cancer frequently seek complementary and alternative (CAM) treatment options that can help to cope with their disease and the side effects of conventional cancer therapy. Especially in Europe, breast cancer patients use herbal products containing mistletoe (Viscum album L.). The oldest and one of the most prescribed conventional drugs for the treatment of estrogen receptor positive breast cancer is tamoxifen. Aside from positive clinical experience with the combination of tamoxifen and mistletoe, little is known about possible herb-drug interactions (HDIs) between the two products. In the present in vitro study, we investigated the effect of standardized commercial mistletoe preparations on the activity of endoxifen, the major active metabolite of tamoxifen. Methods The estrogen receptor positive human breast carcinoma cell line MCF-7 was treated with (E/Z)-endoxifen hydrochloride in the presence and absence of a defined estradiol concentration. Each concentration of the drug was combined with fermented Viscum album L. extracts (VAE) at clinically relevant doses, and proliferation, apoptosis and cell cycle were analyzed. In parallel, possible inhibition of CYP3A4/5 and CYP2D6 was investigated using 50-donor mixed gender pooled human liver microsomes (HLMs). Results VAE did not inhibit endoxifen induced cytostasis and cytotoxicity. At higher concentrations, VAE showed an additive inhibitory effect. VAE preparations did not cause inhibition of CYP3A4/5 and CYP2D6 catalyzed tamoxifen metabolism. Conclusions The in vitro results suggest that mistletoe preparations can be used in combination with tamoxifen without the risk of HDIs. Electronic supplementary material The online version of this article (10.1186/s12906-019-2439-2) contains supplementary material, which is available to authorized users.
Collapse
|
26
|
Jucker T, Wintle B, Shackelford G, Bocquillon P, Geffert JL, Kasoar T, Kovacs E, Mumby HS, Orland C, Schleicher J, Tew ER, Zabala A, Amano T, Bell A, Bongalov B, Chambers JM, Corrigan C, Durán AP, Duvic-Paoli LA, Emilson C, Emilson EJS, da Silva JF, Garnett EE, Green EJ, Guth MK, Hacket-Pain A, Hinsley A, Igea J, Kunz M, Luke SH, Lynam W, Martin PA, Nunes MH, Ockendon N, Pavitt A, Payne CLR, Plutshack V, Rademacher TT, Robertson RJ, Rose DC, Serban A, Simmons BI, Tayleur C, Wordley CFR, Mukherjee N. Ten-year assessment of the 100 priority questions for global biodiversity conservation. Conserv Biol 2018; 32:1457-1463. [PMID: 29923638 DOI: 10.1111/cobi.13159] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/13/2017] [Revised: 06/13/2018] [Accepted: 06/14/2018] [Indexed: 06/08/2023]
Abstract
In 2008, a group of conservation scientists compiled a list of 100 priority questions for the conservation of the world's biodiversity. However, now almost a decade later, no one has yet published a study gauging how much progress has been made in addressing these 100 high-priority questions in the peer-reviewed literature. We took a first step toward reexamining the 100 questions to identify key knowledge gaps that remain. Through a combination of a questionnaire and a literature review, we evaluated each question on the basis of 2 criteria: relevance and effort. We defined highly relevant questions as those that - if answered - would have the greatest impact on global biodiversity conservation and quantified effort based on the number of review publications addressing a particular question, which we used as a proxy for research effort. Using this approach, we identified a set of questions that, despite being perceived as highly relevant, have been the focus of relatively few review publications over the past 10 years. These questions covered a broad range of topics but predominantly tackled 3 major themes: conservation and management of freshwater ecosystems, role of societal structures in shaping interactions between people and the environment, and impacts of conservation interventions. We believe these questions represent important knowledge gaps that have received insufficient attention and may need to be prioritized in future research.
Collapse
Affiliation(s)
- Tommaso Jucker
- Department of Plant Sciences, University of Cambridge, Downing St, Cambridge, CB2 3EA, U.K
- CSIRO Land & Water, 147 Underwood Avenue, Floreat, WA 6014, Australia
| | - Bonnie Wintle
- Centre for the Study of Existential Risk, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, Cambridge, U.K
- School of BioSciences, University of Melbourne, Royal Parade, Parkville, VIC 3010, Australia
| | - Gorm Shackelford
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Pierre Bocquillon
- School of Politics, Philosophy, Language and Communication Studies, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, U.K
- Department of Land Economy, Cambridge Centre for Environment, Energy and Natural Resource Governance, University of Cambridge, 16-21 Silver Street, Cambridge, CB3 9EP, U.K
| | - Jan Laurens Geffert
- Department of Geography, University of Cambridge, 20 Downing Place, Cambridge, CB2 1QB, U.K
- UN Environment World Conservation Monitoring Centre, 219 Huntingdon Road, Cambridge, CB3 0DL, U.K
| | - Tim Kasoar
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Eszter Kovacs
- Department of Geography, University of Cambridge, 20 Downing Place, Cambridge, CB2 1QB, U.K
- Corvinus University of Budapest, Fővám tér 8, Budapest, 1093, Hungary
| | - Hannah S Mumby
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
- Wissenschaftskolleg zu Berlin, Berlin, Germany, Wallotstraße 19, 14193 Berlin, Germany
| | - Chloé Orland
- Department of Plant Sciences, University of Cambridge, Downing St, Cambridge, CB2 3EA, U.K
| | - Judith Schleicher
- Department of Geography, University of Cambridge, 20 Downing Place, Cambridge, CB2 1QB, U.K
- UN Environment World Conservation Monitoring Centre, 219 Huntingdon Road, Cambridge, CB3 0DL, U.K
| | - Eleanor R Tew
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Aiora Zabala
- Department of Land Economy, Cambridge Centre for Environment, Energy and Natural Resource Governance, University of Cambridge, 16-21 Silver Street, Cambridge, CB3 9EP, U.K
| | - Tatsuya Amano
- Centre for the Study of Existential Risk, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, Cambridge, U.K
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Alexandra Bell
- Ministerium für Umwelt, Energie, Ernährung und Forsten, Rheinland Pfalz, Kaiser-Friedrich-Straße 1, 55116 Mainz, Germany
| | - Boris Bongalov
- Department of Plant Sciences, University of Cambridge, Downing St, Cambridge, CB2 3EA, U.K
| | - Josephine M Chambers
- Department of Geography, University of Cambridge, 20 Downing Place, Cambridge, CB2 1QB, U.K
| | - Colleen Corrigan
- UN Environment World Conservation Monitoring Centre, 219 Huntingdon Road, Cambridge, CB3 0DL, U.K
- School of Earth and Environmental Sciences, University of Queensland, St Lucia, QLD 4067, Australia
| | - América P Durán
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
- UN Environment World Conservation Monitoring Centre, 219 Huntingdon Road, Cambridge, CB3 0DL, U.K
- Luc Hoffmann Institute, c/o WWF International, Avenue du Mont Blanc, 1196 Gland, Switzerland
| | - Leslie-Anne Duvic-Paoli
- Department of Land Economy, Cambridge Centre for Environment, Energy and Natural Resource Governance, University of Cambridge, 16-21 Silver Street, Cambridge, CB3 9EP, U.K
| | - Caroline Emilson
- Natural Resources Canada, Great Lakes Forestry Centre, Sault Ste. Marie, ON, P6A 2E5, Canada
| | - Erik J S Emilson
- Department of Plant Sciences, University of Cambridge, Downing St, Cambridge, CB2 3EA, U.K
- Natural Resources Canada, Great Lakes Forestry Centre, Sault Ste. Marie, ON, P6A 2E5, Canada
| | | | - Emma E Garnett
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Elizabeth J Green
- UN Environment World Conservation Monitoring Centre, 219 Huntingdon Road, Cambridge, CB3 0DL, U.K
| | - Miriam K Guth
- UN Environment World Conservation Monitoring Centre, 219 Huntingdon Road, Cambridge, CB3 0DL, U.K
| | - Andrew Hacket-Pain
- Department of Geography and Planning, School of Environmental Science, University of Liverpool, 4 Brownlow Street, Liverpool Merseyside, L69 3GP, U.K
| | - Amy Hinsley
- Interdisciplinary Centre for Conservation Science, Department of Zoology, University of Oxford, 11a Mansfield Road, Oxford, OX1 3SZ, U.K
| | - Javier Igea
- Department of Plant Sciences, University of Cambridge, Downing St, Cambridge, CB2 3EA, U.K
| | - Martina Kunz
- Department of Land Economy, Cambridge Centre for Environment, Energy and Natural Resource Governance, University of Cambridge, 16-21 Silver Street, Cambridge, CB3 9EP, U.K
| | - Sarah H Luke
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
- Durrell Institute of Conservation and Ecology, School of Anthropology and Conservation, The University of Kent, Canterbury, Kent, CT2 7NR, U.K
| | - William Lynam
- Department of Plant Sciences, University of Cambridge, Downing St, Cambridge, CB2 3EA, U.K
| | - Philip A Martin
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Matheus H Nunes
- Department of Plant Sciences, University of Cambridge, Downing St, Cambridge, CB2 3EA, U.K
| | - Nancy Ockendon
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Aly Pavitt
- UN Environment World Conservation Monitoring Centre, 219 Huntingdon Road, Cambridge, CB3 0DL, U.K
| | - Charlotte L R Payne
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Victoria Plutshack
- Department of Land Economy, Cambridge Centre for Environment, Energy and Natural Resource Governance, University of Cambridge, 16-21 Silver Street, Cambridge, CB3 9EP, U.K
| | - Tim T Rademacher
- Department of Geography, University of Cambridge, 20 Downing Place, Cambridge, CB2 1QB, U.K
- Department of Organismic and Evolutionary Biology, Harvard University, 26 Oxford Street, Cambridge, MA 02138, U.S.A
- School of Informatics and Cyber Security and Centre for Ecosystem Science and Society, Northern Arizona University, 1295 Knoles Drive, Flagstaff, AZ 86011, U.S.A
| | - Rebecca J Robertson
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - David C Rose
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
- School of Environmental Sciences, University of East Anglia, Norwich Research Park, Norwich, Norfolk, NR4 7TJ, U.K
| | - Anca Serban
- Department of Geography, University of Cambridge, 20 Downing Place, Cambridge, CB2 1QB, U.K
| | - Benno I Simmons
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Catherine Tayleur
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
- RSPB Centre for Conservation Science, The Lodge, Potton Road, Sandy, Bedfordshire, SG19 2DL, U.K
| | - Claire F R Wordley
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
| | - Nibedita Mukherjee
- Department of Zoology, University of Cambridge, Pembroke Street, Cambridge, CB2 3QZ, U.K
- Centre for Ecology and Conservation, College of Life and Environmental Sciences, University of Exeter, Cornwall Campus, Treliever Road, Penryn, Cornwall TR10 9FE, U.K
| |
Collapse
|
27
|
Stapper MC, Kirchesch D, Krömeke O, Glaas MF, Zollner B, Albert NL, Kunz M. [A rare tympanic lesion - paracentesis led to an interesting diagnosis]. Laryngorhinootologie 2018; 97:636-638. [PMID: 30001563 DOI: 10.1055/a-0648-4710] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
28
|
Haiduk J, Brockstedt LA, Mitter D, Hiemisch A, Merkenschlager A, Simon JC, Kunz M. [Disseminated linear and irregular pigmentation of the skin]. Hautarzt 2018; 69:870-873. [PMID: 29992407 DOI: 10.1007/s00105-018-4231-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J Haiduk
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig, Philipp-Rosenthal-Str. 23, 04103, Leipzig, Deutschland.
| | - L A Brockstedt
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig, Philipp-Rosenthal-Str. 23, 04103, Leipzig, Deutschland
| | - D Mitter
- Institut für Humangenetik, Universitätsklinikum Leipzig, 04103, Leipzig, Deutschland
| | - A Hiemisch
- Klinik für Kinder und Jugendliche, Neuropädiatrie, Universitätsklinikum Leipzig, 04103, Leipzig, Deutschland
| | - A Merkenschlager
- Klinik für Kinder und Jugendliche, Neuropädiatrie, Universitätsklinikum Leipzig, 04103, Leipzig, Deutschland
| | - J C Simon
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig, Philipp-Rosenthal-Str. 23, 04103, Leipzig, Deutschland
| | - M Kunz
- Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig, Philipp-Rosenthal-Str. 23, 04103, Leipzig, Deutschland
| |
Collapse
|
29
|
Bauer M, Glenn T, Alda M, Aleksandrovich MA, Andreassen OA, Angelopoulos E, Ardau R, Ayhan Y, Baethge C, Bharathram SR, Bauer R, Baune BT, Becerra-Palars C, Bellivier F, Belmaker RH, Berk M, Bersudsky Y, Bicakci Ş, Birabwa-Oketcho H, Bjella TD, Bossini L, Cabrera J, Cheung EYW, Del Zompo M, Dodd S, Donix M, Etain B, Fagiolini A, Fountoulakis KN, Frye MA, Gonzalez-Pinto A, Gottlieb JF, Grof P, Harima H, Henry C, Isometsä ET, Janno S, Kapczinski F, Kardell M, Khaldi S, Kliwicki S, König B, Kot TL, Krogh R, Kunz M, Lafer B, Landén M, Larsen ER, Lewitzka U, Licht RW, Lopez-Jaramillo C, MacQueen G, Manchia M, Marsh W, Martinez-Cengotitabengoa M, Melle I, Meza-Urzúa F, Yee Ming M, Monteith S, Morken G, Mosca E, Munoz R, Mythri SV, Nacef F, Nadella RK, Nery FG, Nielsen RE, O'Donovan C, Omrani A, Osher Y, Østermark Sørensen H, Ouali U, Pica Ruiz Y, Pilhatsch M, Pinna M, da Ponte FDR, Quiroz D, Ramesar R, Rasgon N, Reddy MS, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Scippa ÂM, Severus E, Simhandl C, Stein DJ, Strejilevich S, Subramaniam M, Sulaiman AH, Suominen K, Tagata H, Tatebayashi Y, Tondo L, Torrent C, Vaaler AE, Veeh J, Vieta E, Viswanath B, Yoldi-Negrete M, Zetin M, Zgueb Y, Whybrow PC. Solar insolation in springtime influences age of onset of bipolar I disorder. Acta Psychiatr Scand 2017; 136:571-582. [PMID: 28722128 DOI: 10.1111/acps.12772] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/16/2017] [Indexed: 01/19/2023]
Abstract
OBJECTIVE To confirm prior findings that the larger the maximum monthly increase in solar insolation in springtime, the younger the age of onset of bipolar disorder. METHOD Data were collected from 5536 patients at 50 sites in 32 countries on six continents. Onset occurred at 456 locations in 57 countries. Variables included solar insolation, birth-cohort, family history, polarity of first episode and country physician density. RESULTS There was a significant, inverse association between the maximum monthly increase in solar insolation at the onset location, and the age of onset. This effect was reduced in those without a family history of mood disorders and with a first episode of mania rather than depression. The maximum monthly increase occurred in springtime. The youngest birth-cohort had the youngest age of onset. All prior relationships were confirmed using both the entire sample, and only the youngest birth-cohort (all estimated coefficients P < 0.001). CONCLUSION A large increase in springtime solar insolation may impact the onset of bipolar disorder, especially with a family history of mood disorders. Recent societal changes that affect light exposure (LED lighting, mobile devices backlit with LEDs) may influence adaptability to a springtime circadian challenge.
Collapse
Affiliation(s)
- M Bauer
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - T Glenn
- ChronoRecord Association, Fullerton, CA, USA
| | - M Alda
- Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
| | | | - O A Andreassen
- NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - E Angelopoulos
- Department of Psychiatry, Medical School, Eginition Hospital, National and Capodistrian University of Athens, Athens, Greece
| | - R Ardau
- Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy
| | - Y Ayhan
- Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | - C Baethge
- Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, Germany
| | | | - R Bauer
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - B T Baune
- Department of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia
| | - C Becerra-Palars
- National Institute of Psychiatry '"Ramón de la Fuente Muñiz", Mexico City, Mexico
| | - F Bellivier
- Psychiatry and Addiction Medicine, Assistance Publique - Hôpitaux de Paris, FondaMental Foundation, INSERM UMR-S1144, Denis Diderot University, René Descartes University, Paris, France
| | - R H Belmaker
- Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - M Berk
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Vic., Australia.,Department of Psychiatry, Orygen, the National Centre for Excellence in Youth Mental Health, the Centre for Youth Mental Health and the Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Vic., Australia
| | - Y Bersudsky
- Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - Ş Bicakci
- Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | | | - T D Bjella
- NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - L Bossini
- Department of Molecular Medicine and Department of Mental Health (DAI), University of Siena and University of Siena Medical Center (AOUS), Siena, Italy
| | - J Cabrera
- Mood Disorders Clinic, Dr. Jose Horwitz Psychiatric Institute, Santiago de Chile, Chile
| | - E Y W Cheung
- Department of General Adult Psychiatry, Castle Peak Hospital, Tuen Mun, Hong Kong
| | - M Del Zompo
- Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy
| | - S Dodd
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Vic., Australia.,Department of Psychiatry, University of Melbourneo, Parkville, Vic, Australia
| | - M Donix
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - B Etain
- Psychiatry and Addiction Medicine, Assistance Publique - Hôpitaux de Paris, FondaMental Foundation, INSERM UMR-S1144, Denis Diderot University, René Descartes University, Paris, France
| | - A Fagiolini
- Department of Molecular Medicine and Department of Mental Health (DAI), University of Siena and University of Siena Medical Center (AOUS), Siena, Italy
| | - K N Fountoulakis
- Division of Neurosciences, 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - M A Frye
- Department of Psychiatry & Psychology, Mayo Clinic Depression Center, Mayo Clinic, Rochester, MN, USA
| | - A Gonzalez-Pinto
- Department of Psychiatry, University Hospital of Alava, University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - J F Gottlieb
- Department of Psychiatry, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - P Grof
- Mood Disorders Center of Ottawa, University of Toronto, Toronto, ON, Canada
| | - H Harima
- Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Setagaya, Tokyo, Japan
| | - C Henry
- AP-HP, Hopitaux Universitaires Henri Mondor and INSERM U955 (IMRB) and Université Paris Est and Institut Pasteur, Unité Perception et Mémoire, Paris, France
| | - E T Isometsä
- Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.,National Institute for Health and Welfare, Helsinki, Finland
| | - S Janno
- Department of Psychiatry, University of Tartu, Tartu, Estonia
| | - F Kapczinski
- Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | - M Kardell
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - S Khaldi
- Private practice, Tunis, Tunisia
| | - S Kliwicki
- Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland
| | - B König
- BIPOLAR Zentrum Wiener Neustadt, Wiener Neustadt, Austria
| | - T L Kot
- Khanty-Mansiysk Clinical Psychoneurological Hospital, Khanty-Mansiysk, Russia
| | - R Krogh
- Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Aarhus, Denmark
| | - M Kunz
- Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | - B Lafer
- Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil
| | - M Landén
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden.,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - E R Larsen
- Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Aarhus, Denmark
| | - U Lewitzka
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - R W Licht
- Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark.,Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
| | - C Lopez-Jaramillo
- Mood Disorders Program, Hospital Universitario San Vicente Fundación, Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia
| | - G MacQueen
- Department of Psychiatry, Faculty of Medicine, University of Calgary, Calgary, AB, Canada
| | - M Manchia
- Section of Psychiatry, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy
| | - W Marsh
- Department of Psychiatry, University of Massachusetts, Worcester, MA, USA
| | - M Martinez-Cengotitabengoa
- Department of Psychiatry, University Hospital of Alava, University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - I Melle
- NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - F Meza-Urzúa
- National Institute of Psychiatry '"Ramón de la Fuente Muñiz", Mexico City, Mexico
| | - M Yee Ming
- Department of General Psychiatry, Mood Disorders Unit, Institute of Mental Health, Singapore City, Singapore
| | - S Monteith
- Traverse City Campus, Michigan State University College of Human Medicine, Traverse City, MI, USA
| | - G Morken
- Department of Mental Health, Norwegian University of Science and Technology - NTNU, Trondheim, Norway.,Department of Psychiatry, St Olavs' University Hospital, Trondheim, Norway
| | - E Mosca
- Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy
| | - R Munoz
- Department of Psychiatry, University of California San Diego, San Diego, CA, USA
| | - S V Mythri
- Asha Bipolar Clinic, Asha Hospital, Hyderabad, Telangana, India
| | - F Nacef
- Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia
| | - R K Nadella
- Department of Psychiatry, NIMHANS, Bangalore, India
| | - F G Nery
- Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil
| | - R E Nielsen
- Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark.,Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
| | - C O'Donovan
- Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
| | - A Omrani
- Tunisian Bipolar Forum, Érable Médical Cabinet 324, Tunis, Tunisia
| | - Y Osher
- Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - H Østermark Sørensen
- Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark
| | - U Ouali
- Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia
| | - Y Pica Ruiz
- Hospital "Ángeles del Pedregal", Mexico City, Mexico
| | - M Pilhatsch
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - M Pinna
- Lucio Bini Mood Disorder Center, Cagliari, Italy
| | - F D R da Ponte
- Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | - D Quiroz
- Deparment of Psychiatry, Diego Portales University, Santiago de Chile, Chile
| | - R Ramesar
- UCT/MRC Human Genetics Research Unit, Division of Human Genetics, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
| | - N Rasgon
- Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Palo Alto, CA, USA
| | - M S Reddy
- Asha Bipolar Clinic, Asha Hospital, Hyderabad, Telangana, India
| | - A Reif
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
| | - P Ritter
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - J K Rybakowski
- Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland
| | - K Sagduyu
- Department of Psychiatry, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
| | - Â M Scippa
- Department of Neuroscience and Mental Health, Federal University of Bahia, Salvador, Brazil
| | - E Severus
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - C Simhandl
- BIPOLAR Zentrum Wiener Neustadt, Wiener Neustadt, Austria
| | - D J Stein
- Department of Psychiatry, MRC Unit on Risk & Resilience in Mental Disorders, University of Cape Town, Cape Town, South Africa
| | - S Strejilevich
- Bipolar Disorder Program, Neuroscience Institute, Favaloro University, Buenos Aires, Argentina
| | - M Subramaniam
- Research Division, Institute of Mental Health, Singapore City, Singapore
| | - A H Sulaiman
- Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - K Suominen
- Department of Social Services and Health Care, Psychiatry, City of Helsinki, Helsinki, Finland
| | - H Tagata
- Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Setagaya, Tokyo, Japan
| | - Y Tatebayashi
- Schizophrenia & Affective Disorders Research Project, Tokyo Metropolitan Institute of Medical Science, Seatagaya, Tokyo, Japan
| | - L Tondo
- McLean Hospital-Harvard Medical School, Boston, MA, USA.,Mood Disorder Lucio Bini Centers, Cagliari e Roma, Italy
| | - C Torrent
- Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
| | - A E Vaaler
- Department of Mental Health, Norwegian University of Science and Technology - NTNU, Trondheim, Norway.,Department of Psychiatry, St Olavs' University Hospital, Trondheim, Norway
| | - J Veeh
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
| | - E Vieta
- Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
| | - B Viswanath
- Department of Psychiatry, NIMHANS, Bangalore, India
| | - M Yoldi-Negrete
- Consejo Nacional de Ciencia y Tecnología - Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico
| | - M Zetin
- Department of Psychology, Chapman University, Orange, CA, USA
| | - Y Zgueb
- Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia
| | - P C Whybrow
- Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior University of California Los Angeles (UCLA), Los Angeles, CA, USA
| |
Collapse
|
30
|
Kunz M, Capito ES, Horn-Hofmann C, Baum C, Scheel J, Karmann AJ, Priebe JA, Lautenbacher S. Psychometric Properties of the German Version of the Pain Vigilance and Awareness Questionnaire (PVAQ) in Pain-Free Samples and Samples with Acute and Chronic Pain. Int J Behav Med 2017; 24:260-271. [PMID: 27481106 PMCID: PMC5344944 DOI: 10.1007/s12529-016-9585-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Purpose The way individuals attend to pain is known to have a considerable impact on the experience and chronification of pain. One method to assess the habitual “attention to pain” is the Pain Vigilance and Awareness Questionnaire (PVAQ). With the present study, we aimed to test the psychometric properties of the German version of the PVAQ across pain-free samples and across patients with acute and chronic pain. Method Two samples of pain-free individuals (student sample (N = 255)/non-student sample (N = 362)) and two clinical pain samples (acute pain patients (N = 105)/chronic pain patients (N = 36)) were included in this cross-sectional evaluation of the German PVAQ. Factor structure was assessed using exploratory and confirmatory factor analyses. Reliability was assessed using internal consistency (Cronbach’s alpha). Construct validity was tested by assessing correlations between PVAQ and theoretically related constructs. Results Exploratory factor analysis (non-student sample) and confirmatory factor analysis (student sample, acute pain patient sample) suggested that a two-factor solution best fitted our data (“attention to pain,” “attention to changes in pain”). Internal consistency ranged from acceptable to good in all four samples. As hypothesized, the PVAQ correlated significantly with theoretically related constructs in all four samples, suggesting good construct validity in pain-free individuals and in pain patients. Conclusion The German PVAQ shows good psychometric properties across samples of pain-free individuals and patients suffering from pain that are comparable to PVAQ versions of other languages. Thus, the German PVAQ seems to be a measure of pain vigilance equally valid as found in other countries.
Collapse
Affiliation(s)
- M Kunz
- Physiological Psychology, University of Bamberg, Bamberg, Germany.
- Department of Family Medicine, Geriatrics Section, University Medical Center Groningen, Groningen, the Netherlands.
| | - E S Capito
- Physiological Psychology, University of Bamberg, Bamberg, Germany
| | - C Horn-Hofmann
- Physiological Psychology, University of Bamberg, Bamberg, Germany
| | - C Baum
- Physiological Psychology, University of Bamberg, Bamberg, Germany
- Psychology School, Hochschule Fresenius University of Applied Sciences, Frankfurt, Germany
| | - J Scheel
- Physiological Psychology, University of Bamberg, Bamberg, Germany
| | - A J Karmann
- Physiological Psychology, University of Bamberg, Bamberg, Germany
| | - J A Priebe
- Physiological Psychology, University of Bamberg, Bamberg, Germany
| | - S Lautenbacher
- Physiological Psychology, University of Bamberg, Bamberg, Germany
| |
Collapse
|
31
|
Abstract
AimTo assess the clinical outcomes associated with social cognition impairment in euthymic patients with bipolar disorder.MethodIt was a cross-sectional study with convenience sample. The diagnose of bipolar disorder was performed by psychiatrist, using DSM-IV criteria, at bipolar disorder program – Hospital de Clinicas de Porto Alegre (Brazil), where the sample was recruited. The social cognition was assessed by psychologists using the Reading the Mind in the Eyes Test.ResultsWe included 46 euthymic BD patients: BD I (n = 39), women (n = 32), age (49.11 ± 13.17), and years of education (10.56 ± 3.80). Patients with social cognition impairment were not different of patients without social cognition impairment regarding socio demographic factors (gender, age, educational level, marital status, and employment status). Patients with social cognitive impairment showed higher rates of BD I patients (P = 0.036) and higher proportion of hospitalization in the first episode (P = 0.033), as compared to patients without social cognition impairment.ConclusionThis is a preliminary study demonstrating that BD patients with social cognition impairment show worse clinical outcomes. Severe BD onset seems to be an important predictor of social cognition impairment. However, more studies are needed investigating social cognition impairment in subjects with bipolar disorder.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
32
|
Ponte F, Cardoso T, Kunz M, Rosa A. Social cognition and bipolar disorder: A preliminary study. Eur Psychiatry 2017. [DOI: 10.1016/j.eurpsy.2017.01.396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Abstract
AimTo assess the clinical outcomes associated with social cognition impairment in euthymic patients with bipolar disorder.MethodIt was a cross-sectional study with convenience sample. The diagnose of bipolar disorder was performed by psychiatrist, using DSM-IV criteria, at bipolar disorder program – Hospital de Clinicas de Porto Alegre (Brazil), where the sample was recruited. The social cognition was assessed by psychologists using the Reading the Mind in the Eyes Test.ResultsWe included 46 euthymic BD patients: BD I (n = 39), women (n = 32), age (49.11 ± 13.17), and years of education (10.56 ± 3.80). Patients with social cognition impairment were not different of patients without social cognition impairment regarding socio demographic factors (gender, age, educational level, marital status, and employment status). Patients with social cognitive impairment showed higher rates of BD I patients (P = 0.036) and higher proportion of hospitalization in the first episode (P = 0.033), as compared to patients without social cognition impairment.ConclusionThis is a preliminary study demonstrating that BD patients with social cognition impairment show worse clinical outcomes. Severe BD onset seems to be an important predictor of social cognition impairment. However, more studies are needed investigating social cognition impairment in subjects with bipolar disorder.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
33
|
Adcock CT, Tschauner O, Hausrath EM, Udry A, Luo SN, Cai Y, Ren M, Lanzirotti A, Newville M, Kunz M, Lin C. Shock-transformation of whitlockite to merrillite and the implications for meteoritic phosphate. Nat Commun 2017; 8:14667. [PMID: 28262701 PMCID: PMC5343502 DOI: 10.1038/ncomms14667] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2016] [Accepted: 01/23/2017] [Indexed: 11/17/2022] Open
Abstract
Meteorites represent the only samples available for study on Earth of a number of planetary bodies. The minerals within meteorites therefore hold the key to addressing numerous questions about our solar system. Of particular interest is the Ca-phosphate mineral merrillite, the anhydrous end-member of the merrillite–whitlockite solid solution series. For example, the anhydrous nature of merrillite in Martian meteorites has been interpreted as evidence of water-limited late-stage Martian melts. However, recent research on apatite in the same meteorites suggests higher water content in melts. One complication of using meteorites rather than direct samples is the shock compression all meteorites have experienced, which can alter meteorite mineralogy. Here we show whitlockite transformation into merrillite by shock-compression levels relevant to meteorites, including Martian meteorites. The results open the possibility that at least part of meteoritic merrillite may have originally been H+-bearing whitlockite with implications for interpreting meteorites and the need for future sample return. Quantifying the amount of water in meteorites remains challenging, with minerals the key to understanding water contents. Here, Adcock et al. perform shock experiments on H+-bearing whitlockite demonstrating that it may transform into anhydrous merrillite, which is commonly found in Martian meteorites.
Collapse
Affiliation(s)
- C T Adcock
- Department of Geoscience, University of Nevada, Las Vegas, 4505 South Maryland Parkway, Las Vegas, Nevada 89154, USA
| | - O Tschauner
- Department of Geoscience, University of Nevada, Las Vegas, 4505 South Maryland Parkway, Las Vegas, Nevada 89154, USA.,High Pressure Science and Engineering Center, University of Nevada, Las Vegas, 4505 South Maryland Parkway, Las Vegas, Nevada 89154, USA.,LSPM-CNRS, Institut Galilée, Université Paris 13, Nord, 99, av. J. B. Clément, 93430 Villetaneuse, France.,Key Laboratory of Advanced Technologies of Materials, Ministry of Education, Southwest Jiaotong University, Chengdu, Sichuan 610031, China
| | - E M Hausrath
- Department of Geoscience, University of Nevada, Las Vegas, 4505 South Maryland Parkway, Las Vegas, Nevada 89154, USA
| | - A Udry
- Department of Geoscience, University of Nevada, Las Vegas, 4505 South Maryland Parkway, Las Vegas, Nevada 89154, USA
| | - S N Luo
- Key Laboratory of Advanced Technologies of Materials, Ministry of Education, Southwest Jiaotong University, Chengdu, Sichuan 610031, China.,The Peac Institute of Multiscale Sciences, Chengdu, Sichuan 610031, China
| | - Y Cai
- The Peac Institute of Multiscale Sciences, Chengdu, Sichuan 610031, China.,CAS Key Laboratory of Materials Behavior and Design, Department of Modern Mechanics, University of Science and Technology of China, Hefei, Anhui 230027, China
| | - M Ren
- Department of Geoscience, University of Nevada, Las Vegas, 4505 South Maryland Parkway, Las Vegas, Nevada 89154, USA
| | - A Lanzirotti
- GeoScienceEnviro Center for Advanced Radiation Sources, University of Chicago, Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M Newville
- GeoScienceEnviro Center for Advanced Radiation Sources, University of Chicago, Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M Kunz
- Lawrence Berkeley National Laboratory, Advanced Light Source, University of California, Berkeley, Berkeley, California 94720, USA
| | - C Lin
- High Pressure Collaborative Access Team (HPCAT), Geophysical Laboratory, Carnegie Institution of Washington, Argonne, Illinois 60439, USA
| |
Collapse
|
34
|
Kunz M. Aktuelle molekulare Diagnostik beim malignen Melanom. Akt Dermatol 2017. [DOI: 10.1055/s-0042-116033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- M. Kunz
- Klinik für Dermatologie, Venerologie und Allergologie, Universität Leipzig
| |
Collapse
|
35
|
Thurneysen S, Cheng PF, Nagel HW, Kunz M, Jaberg-Bentele N, Nägeli M, Ziegler M, Guenova E, Goldinger SM, Mangana J, Levesque MP, Dummer R. An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel. Br J Dermatol 2016; 175:966-978. [PMID: 27168024 DOI: 10.1111/bjd.14727] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/03/2016] [Indexed: 12/13/2022]
Abstract
BACKGROUND There is a medical need for new drugs in patients with BRAF wild-type metastatic melanoma. Pazopanib is a multitarget tyrosine kinase inhibitor with antitumour and antiangiogenic activity. OBJECTIVES The primary aim was to investigate the metabolic response to pazopanib monotherapy and pazopanib plus paclitaxel in patients with BRAF wild-type melanoma. Secondary end points were the early cytokine and chemokine profiles and histological findings. METHODS Pazopanib (400 mg twice daily) was administered orally from days 1 to 10 and from days 14 to 70. An intravenous infusion with paclitaxel (150 mg m-2 body surface) was administered on days 14, 35 and 56. Metabolic response evaluation was performed before treatment, after treatment with pazopanib (day 10) and after treatment with pazopanib and paclitaxel (day 70). Skin biopsy of metastatic tissue for chemokine and cytokine expression analysis and histology and immunohistochemistry (CD68, CD163) evaluation, and blood samples were taken at the same time points. RESULTS Two patients failed screening and 17 were dosed. Of 67 adverse events, nine (13%) were grade 3 or 4. Five of 14 evaluable patients had a partial metabolic response at day 10 under pazopanib monotherapy. The response rate at day 70 under combined pazopanib-paclitaxel treatment was 0%. Immunohistochemistry revealed an increase of M2-like macrophages in nonresponders compared with responders. We observed a significant upregulation of five cytokines (CXCL1, CXCL2, CXCL13, CCL22 and SPP1) in responding vs. nonresponding lesions. Overall, the median progression-free survival was 70 days (range 5-331), which did not differ significantly between responders (148 days) and nonresponders (70 days, P = 0·17). CONCLUSIONS In this patient population pazopanib efficacy was limited. Response is associated with low M2-like macrophage density and increased expression of several chemokines.
Collapse
Affiliation(s)
- S Thurneysen
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - P F Cheng
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - H W Nagel
- Department of Nuclear Medicine, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - M Kunz
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - N Jaberg-Bentele
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - M Nägeli
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - M Ziegler
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - E Guenova
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - S M Goldinger
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - J Mangana
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - M P Levesque
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland
| | - R Dummer
- Department of Dermatology, University Hospital Zurich, Gloriastraße 31, 8091, Zurich, Switzerland.
| |
Collapse
|
36
|
Weissenstein U, Kunz M, Urech K, Regueiro U, Baumgartner S. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro. Altern Ther Health Med 2016; 16:271. [PMID: 27491866 PMCID: PMC4973521 DOI: 10.1186/s12906-016-1246-2] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2016] [Accepted: 07/23/2016] [Indexed: 11/10/2022]
Abstract
Background Besides conventional anticancer therapy many breast cancer patients use complementary and alternative medicine (CAM) like the medicinal herb mistletoe (Viscum album L.). To gain more knowledge about possible herb-drug interactions between CAM and conventional anticancer medications, in the present in vitro study we investigated the effect of a standardized mistletoe preparation on the action of Trastuzumab, a drug used for the treatment of Her-2 positive breast cancer. Methods The Her-2 positive human breast carcinoma cell line SK-BR-3 was treated with Trastuzumab. Different doses of the drug were combined with Viscum album extract (VAE) in clinically relevant doses. Proliferation, apoptosis, cell cycle and the secretion of vascular endothelial growth factor (VEGF) were analyzed. Results No inhibition of antitumor efficacy of Trastuzumab by VAE was detected. VAE and Trastuzumab, either alone or in combination, inhibited proliferation of SK-BR-3 cells in vitro. At higher concentrations VAE induced apoptosis, which was not observed for Trastuzumab. Cells treated with Trastuzumab underwent a G0/G1 cell cycle arrest and cells treated with VAE a G2/M arrest. After application of the two drugs in combination both G0/G1 and G2/M arrest was observed. VEGF secretion of SK-BR-3 cells was significantly inhibited by sole treatment with Trastuzumab or VAE. Combined treatment of Trastuzumab and VAE at clinically relevant doses showed additive inhibitory effects on VEGF secretion. Conclusions VAE did not interfere with cytostatic effects of Trastuzumab on SK-BR-3 cells in vitro. Our in vitro results suggest that no risk of safety by herb drug interactions has to be expected from the exposition of cancer cells to Trastuzumab and VAE simultaneously. In contrast, VAE and Trastuzumab seem to exhibit complementary anti-cancer effects in vitro.
Collapse
|
37
|
Affiliation(s)
- M Kunz
- Physiological Psychology, University of Bamberg, Germany
| |
Collapse
|
38
|
Abstract
ObjectivesTo evaluate the prevalence and associated variables of intentional self-poisoning in individuals from 8 to 17 years.MethodThis study includes 4658 cases. Analyzed variables were gender, age, agent and time (month, week day and hour).ResultsIn total, 3759 (80.70%) were girls. The rate in 100,000 children and adolescents residents grown from 25.12 in 2005 to 35.24 to 2012. The biggest incidence was in the 15 to 17 age group (63.35%). The leading agent was medications (84.6%): 1093 (23.47%) antidepressant, 967 (20.76%) benzodiazepines, 708 (15.20%) antipyretics, 606 (13.01%) anticonvulsants, 460 (9.88%) neuroleptics and 382 (8.2%) anti-inflammatory non-steroids. The antidepressant more used was amitriptyline (7.26%), followed by fluoxetine (6.57%). Growing cases involving selective serotonin reuptake inhibitors have been seen, as a fall of self-poisoning tricyclic antidepressants cases. The majority of cases was in October (10.1%), on Tuesday (15.1%), and at 18:00 to 21:00 (29.46%).ConclusionThe elevated rate of self-poisoning in children and adolescents in southern Brazil, growing each year, shows the relevance of this subject. It is important to considerate how easily these children and adolescents have access to psychotropics.
Collapse
|
39
|
Kunz M, Urosevic-Maiwald M, Goldinger S, Frauchiger A, Dreier J, Belloni B, Mangana J, Jenni D, Dippel M, Cozzio A, Guenova E, Kamarachev J, French L, Dummer R. Efficacy and safety of oral alitretinoin in severe oral lichen planus - results of a prospective pilot study. J Eur Acad Dermatol Venereol 2015; 30:293-8. [DOI: 10.1111/jdv.13444] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2015] [Accepted: 09/04/2015] [Indexed: 11/29/2022]
Affiliation(s)
- M. Kunz
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | | | - S.M. Goldinger
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - A.L. Frauchiger
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - J. Dreier
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - B. Belloni
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - J. Mangana
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - D. Jenni
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - M. Dippel
- MD Medscript; Health Care Consulting and Writing; Bad Durkheim Germany
| | - A. Cozzio
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - E. Guenova
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - J. Kamarachev
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - L.E. French
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| | - R. Dummer
- Department of Dermatology; University Hospital Zurich; Zurich Switzerland
| |
Collapse
|
40
|
Kunz M, Balaketheeswaran S, Ellis RE, Rudan JF. The influence of osteophyte depiction in CT for patient-specific guided hip resurfacing procedures. Int J Comput Assist Radiol Surg 2015; 10:717-26. [PMID: 25861892 DOI: 10.1007/s11548-015-1200-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2015] [Accepted: 04/01/2015] [Indexed: 12/25/2022]
Abstract
PURPOSE An accurate fit of a patient-specific instrument guide during an intervention is one of the critical factors affecting accuracy of the surgical procedure. In this study, we investigated how well osteophytes, which are abnormal bone growths that form along joints, are depicted in clinical preoperative CT scans and estimated the influence of such depiction errors on the intraoperative accuracy of the guide. METHODS In 34 hip resurfacing patients, 227 osteophyte surface points on the anterior aspect of the femoral neck were collected intraoperatively, using an optoelectronic navigation system. These points were registered to a preoperative CT scan of the patient, and distances between collected points and segmented virtual bone surface, as well as Hounsfield units for these points, were determined. We simulated the registration error of a patient-specific guide, using a modified registration algorithm, to test placement on the anterior aspect of the femoral neck without removing any osteophytes. This error was then applied to the surgical plan of the femoral central-pin position and orientation for evaluation. RESULTS The average distance between the collected points and the segmented surface was 2.6 mm. We estimated the average error for the entrance point of the central-pin to be 0.7 mm in the distal direction and 3.2 mm in the anterior direction. The average orientation error was 2.8° in anteversion. CONCLUSIONS The depiction of osteophytes in clinical preoperative CT scans for proximal femurs can be unreliable and can possibly result in significant intraoperative instrument alignment errors during image-guided surgeries.
Collapse
Affiliation(s)
- M Kunz
- School of Computing, Queen's University, 557 Goodwin Hall, Kingston, ON, K7L 2N8, Canada,
| | | | | | | |
Collapse
|
41
|
Suchorska B, Kunz M, Schniepp R, Jahn K, Goetz C, Tonn JC, Peraud A. Optimized surgical treatment for normal pressure hydrocephalus: comparison between gravitational and differential pressure valves. Acta Neurochir (Wien) 2015; 157:703-9. [PMID: 25666108 DOI: 10.1007/s00701-015-2345-4] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2014] [Accepted: 01/05/2015] [Indexed: 11/29/2022]
Abstract
OBJECTIVES In idiopathic normal pressure hydrocephalus (NPH) ventriculoperitoneal (VP) shunt insertion is the method of choice to improve cardinal symptoms such as gait disturbance, urge incontinence and/or dementia. With reduced compliance, the brain of the elderly is prone for overdrainage complications. This was especially true with the use of differential pressure valve implantation. The present study compares clinical outcome and complication rates after VP shunt insertion with differential pressure valves in the early years and gravitational valves since 2005. METHODS The authors reviewed patients treated at our institution for NPH since 1995. Differential pressure valves were solely used in the initial years, while the treatment regimen changed to gravitational valves in 2005. Clinical improvement/surgical success rates as well as complications were compared between the two groups. RESULTS Eighty-nine patients were enrolled for the present study. Mean age at the time of surgery was 73.5 ± 6.3 years. Male patients predominated with 73, compared with 16 female patients. Median follow-up time was 28 ± 26 months. Date of last follow-up was 1st October 2013. Forty-nine patients received a gravitational valve, while 40 were treated with differential pressure valves. In the gravitational group a significant improvement was observed after shunt insertion for gait disorder, cognitive impairment and urge incontinence (p < 0.0001, resp. p = 0.004), while a significant change in the differential pressure group was only seen for gait disorder (p = 0.03) but not for cognition or urinary incontinency (p > 0.05). The risk of hygroma as a sign of shunt overdrainage requiring surgical intervention was significantly higher in the differential pressure group (5 versus 0 in the gravitational group). CONCLUSIONS Patients with NPH treated with gravitational valves in the present cohort showed a more profound improvement in their initial symptoms, including gait disorder, cognitive impairment and urinary incontinency without the risk of overdrainage complications requiring surgical intervention when compared with patients who received differential pressure valves in previous years.
Collapse
Affiliation(s)
- B Suchorska
- Klinikum Großhadern, Neurochirurgische Klinik und Poliklinik, Marchioninistrasse 15, 81377, München, Germany
| | | | | | | | | | | | | |
Collapse
|
42
|
Affiliation(s)
| | - G Venne
- DBMS Queen's UniversityKingstonONCanada
| | - R Easteal
- DBMS Queen's UniversityKingstonONCanada
| | | |
Collapse
|
43
|
Ade PAR, Aghanim N, Ahmed Z, Aikin RW, Alexander KD, Arnaud M, Aumont J, Baccigalupi C, Banday AJ, Barkats D, Barreiro RB, Bartlett JG, Bartolo N, Battaner E, Benabed K, Benoît A, Benoit-Lévy A, Benton SJ, Bernard JP, Bersanelli M, Bielewicz P, Bischoff CA, Bock JJ, Bonaldi A, Bonavera L, Bond JR, Borrill J, Bouchet FR, Boulanger F, Brevik JA, Bucher M, Buder I, Bullock E, Burigana C, Butler RC, Buza V, Calabrese E, Cardoso JF, Catalano A, Challinor A, Chary RR, Chiang HC, Christensen PR, Colombo LPL, Combet C, Connors J, Couchot F, Coulais A, Crill BP, Curto A, Cuttaia F, Danese L, Davies RD, Davis RJ, de Bernardis P, de Rosa A, de Zotti G, Delabrouille J, Delouis JM, Désert FX, Dickinson C, Diego JM, Dole H, Donzelli S, Doré O, Douspis M, Dowell CD, Duband L, Ducout A, Dunkley J, Dupac X, Dvorkin C, Efstathiou G, Elsner F, Enßlin TA, Eriksen HK, Falgarone E, Filippini JP, Finelli F, Fliescher S, Forni O, Frailis M, Fraisse AA, Franceschi E, Frejsel A, Galeotta S, Galli S, Ganga K, Ghosh T, Giard M, Gjerløw E, Golwala SR, González-Nuevo J, Górski KM, Gratton S, Gregorio A, Gruppuso A, Gudmundsson JE, Halpern M, Hansen FK, Hanson D, Harrison DL, Hasselfield M, Helou G, Henrot-Versillé S, Herranz D, Hildebrandt SR, Hilton GC, Hivon E, Hobson M, Holmes WA, Hovest W, Hristov VV, Huffenberger KM, Hui H, Hurier G, Irwin KD, Jaffe AH, Jaffe TR, Jewell J, Jones WC, Juvela M, Karakci A, Karkare KS, Kaufman JP, Keating BG, Kefeli S, Keihänen E, Kernasovskiy SA, Keskitalo R, Kisner TS, Kneissl R, Knoche J, Knox L, Kovac JM, Krachmalnicoff N, Kunz M, Kuo CL, Kurki-Suonio H, Lagache G, Lähteenmäki A, Lamarre JM, Lasenby A, Lattanzi M, Lawrence CR, Leitch EM, Leonardi R, Levrier F, Lewis A, Liguori M, Lilje PB, Linden-Vørnle M, López-Caniego M, Lubin PM, Lueker M, Macías-Pérez JF, Maffei B, Maino D, Mandolesi N, Mangilli A, Maris M, Martin PG, Martínez-González E, Masi S, Mason P, Matarrese S, Megerian KG, Meinhold PR, Melchiorri A, Mendes L, Mennella A, Migliaccio M, Mitra S, Miville-Deschênes MA, Moneti A, Montier L, Morgante G, Mortlock D, Moss A, Munshi D, Murphy JA, Naselsky P, Nati F, Natoli P, Netterfield CB, Nguyen HT, Nørgaard-Nielsen HU, Noviello F, Novikov D, Novikov I, O'Brient R, Ogburn RW, Orlando A, Pagano L, Pajot F, Paladini R, Paoletti D, Partridge B, Pasian F, Patanchon G, Pearson TJ, Perdereau O, Perotto L, Pettorino V, Piacentini F, Piat M, Pietrobon D, Plaszczynski S, Pointecouteau E, Polenta G, Ponthieu N, Pratt GW, Prunet S, Pryke C, Puget JL, Rachen JP, Reach WT, Rebolo R, Reinecke M, Remazeilles M, Renault C, Renzi A, Richter S, Ristorcelli I, Rocha G, Rossetti M, Roudier G, Rowan-Robinson M, Rubiño-Martín JA, Rusholme B, Sandri M, Santos D, Savelainen M, Savini G, Schwarz R, Scott D, Seiffert MD, Sheehy CD, Spencer LD, Staniszewski ZK, Stolyarov V, Sudiwala R, Sunyaev R, Sutton D, Suur-Uski AS, Sygnet JF, Tauber JA, Teply GP, Terenzi L, Thompson KL, Toffolatti L, Tolan JE, Tomasi M, Tristram M, Tucci M, Turner AD, Valenziano L, Valiviita J, Van Tent B, Vibert L, Vielva P, Vieregg AG, Villa F, Wade LA, Wandelt BD, Watson R, Weber AC, Wehus IK, White M, White SDM, Willmert J, Wong CL, Yoon KW, Yvon D, Zacchei A, Zonca A. Joint analysis of BICEP2/keck array and Planck Data. Phys Rev Lett 2015; 114:101301. [PMID: 25815919 DOI: 10.1103/physrevlett.114.101301] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2015] [Indexed: 06/04/2023]
Abstract
We report the results of a joint analysis of data from BICEP2/Keck Array and Planck. BICEP2 and Keck Array have observed the same approximately 400 deg^{2} patch of sky centered on RA 0 h, Dec. -57.5°. The combined maps reach a depth of 57 nK deg in Stokes Q and U in a band centered at 150 GHz. Planck has observed the full sky in polarization at seven frequencies from 30 to 353 GHz, but much less deeply in any given region (1.2 μK deg in Q and U at 143 GHz). We detect 150×353 cross-correlation in B modes at high significance. We fit the single- and cross-frequency power spectra at frequencies ≥150 GHz to a lensed-ΛCDM model that includes dust and a possible contribution from inflationary gravitational waves (as parametrized by the tensor-to-scalar ratio r), using a prior on the frequency spectral behavior of polarized dust emission from previous Planck analysis of other regions of the sky. We find strong evidence for dust and no statistically significant evidence for tensor modes. We probe various model variations and extensions, including adding a synchrotron component in combination with lower frequency data, and find that these make little difference to the r constraint. Finally, we present an alternative analysis which is similar to a map-based cleaning of the dust contribution, and show that this gives similar constraints. The final result is expressed as a likelihood curve for r, and yields an upper limit r_{0.05}<0.12 at 95% confidence. Marginalizing over dust and r, lensing B modes are detected at 7.0σ significance.
Collapse
Affiliation(s)
- P A R Ade
- School of Physics and Astronomy, Cardiff University, Queens Buildings, The Parade, Cardiff, CF24 3AA, United Kingdom
| | - N Aghanim
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - Z Ahmed
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - R W Aikin
- California Institute of Technology, Pasadena, California, USA
| | - K D Alexander
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - M Arnaud
- Laboratoire AIM, IRFU/Service d'Astrophysique-CEA/DSM-CNRS-Université Paris Diderot, Bâtiment 709, CEA-Saclay, F-91191 Gif-sur-Yvette Cedex, France
| | - J Aumont
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - C Baccigalupi
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
| | - A J Banday
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - D Barkats
- Joint ALMA Observatory, Vitacura, Santiago, Chile
| | - R B Barreiro
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - J G Bartlett
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - N Bartolo
- Dipartimento di Fisica e Astronomia G. Galilei, Università degli Studi di Padova, via Marzolo 8, 35131 Padova, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, via Marzolo 8, I-35131 Padova, Italy
| | - E Battaner
- University of Granada, Departamento de Física Teórica y del Cosmos, Facultad de Ciencias, Granada, Spain
- University of Granada, Instituto Carlos I de Física Teórica y Computacional, Granada, Spain
| | - K Benabed
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
| | - A Benoît
- Institut Néel, CNRS, Université Joseph Fourier Grenoble I, 25 rue des Martyrs, Grenoble, France
| | - A Benoit-Lévy
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
- Department of Physics and Astronomy, University College London, London WC1E 6BT, United Kingdom
| | - S J Benton
- Department of Physics, University of Toronto, Toronto, Ontario, M5S 1A7, Canada
| | - J-P Bernard
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - M Bersanelli
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - P Bielewicz
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - C A Bischoff
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - J J Bock
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - A Bonaldi
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - L Bonavera
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - J R Bond
- CITA, University of Toronto, 60 St. George Street, Toronto, Ontario M5S 3H8, Canada
| | - J Borrill
- Computational Cosmology Center, Lawrence Berkeley National Laboratory, Berkeley, California, USA
- Space Sciences Laboratory, University of California, Berkeley, California, USA
| | - F R Bouchet
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- Sorbonne Université-UPMC, UMR7095, Institut d'Astrophysique de Paris, 98 bis Boulevard Arago, F-75014, Paris, France
| | - F Boulanger
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - J A Brevik
- California Institute of Technology, Pasadena, California, USA
| | - M Bucher
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - I Buder
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - E Bullock
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C Burigana
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Via Saragat 1, 44122 Ferrara, Italy
- INFN, Sezione di Bologna, Via Irnerio 46, I-40126, Bologna, Italy
| | - R C Butler
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - V Buza
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - E Calabrese
- Sub-Department of Astrophysics, University of Oxford, Keble Road, Oxford OX1 3RH, United Kingdom
| | - J-F Cardoso
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- Laboratoire Traitement et Communication de l'Information, CNRS (UMR 5141) and Télécom ParisTech, 46 rue Barrault F-75634 Paris Cedex 13, France
| | - A Catalano
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - A Challinor
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
- Centre for Theoretical Cosmology, DAMTP, University of Cambridge, Wilberforce Road, Cambridge CB3 0WA, United Kingdom
| | - R-R Chary
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, California 91125, USA
| | - H C Chiang
- Department of Physics, Princeton University, Princeton, New Jersey, USA
- Astrophysics & Cosmology Research Unit, School of Mathematics, Statistics & Computer Science, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, Durban 4000, South Africa
| | - P R Christensen
- Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
- Discovery Center, Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
| | - L P L Colombo
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- Department of Physics and Astronomy, Dana and David Dornsife College of Letter, Arts and Sciences, University of Southern California, Los Angeles, California 90089, USA
| | - C Combet
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - J Connors
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - F Couchot
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - A Coulais
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - B P Crill
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - A Curto
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
- Astrophysics Group, Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 0HE, United Kingdom
| | - F Cuttaia
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - L Danese
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
| | - R D Davies
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - R J Davis
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - P de Bernardis
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
| | - A de Rosa
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - G de Zotti
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
- INAF-Osservatorio Astronomico di Padova, Vicolo dell'Osservatorio 5, Padova, Italy
| | - J Delabrouille
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - J-M Delouis
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
| | - F-X Désert
- IPAG: Institut de Planétologie et d'Astrophysique de Grenoble, Université Grenoble Alpes, IPAG, F-38000 Grenoble, France, CNRS, IPAG, F-38000 Grenoble, France
| | - C Dickinson
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - J M Diego
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - H Dole
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- Institut Universitaire de France, 103, bd Saint-Michel, 75005, Paris, France
| | - S Donzelli
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - O Doré
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - M Douspis
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - C D Dowell
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - L Duband
- Service des Basses Températures, Commissariat à l'Energie Atomique, 38054 Grenoble, France
| | - A Ducout
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- Imperial College London, Astrophysics group, Blackett Laboratory, Prince Consort Road, London, SW7 2AZ, United Kingdom
| | - J Dunkley
- Sub-Department of Astrophysics, University of Oxford, Keble Road, Oxford OX1 3RH, United Kingdom
| | - X Dupac
- European Space Agency, ESAC, Planck Science Office, Camino bajo del Castillo, s/n, Urbanización Villafranca del Castillo, Villanueva de la Cañada, Madrid, Spain
| | - C Dvorkin
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - G Efstathiou
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
| | - F Elsner
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
- Department of Physics and Astronomy, University College London, London WC1E 6BT, United Kingdom
| | - T A Enßlin
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - H K Eriksen
- Institute of Theoretical Astrophysics, University of Oslo, Blindern, Oslo, Norway
| | - E Falgarone
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - J P Filippini
- California Institute of Technology, Pasadena, California, USA
- Department of Physics, University of Illinois at Urbana-Champaign, 1110 West Green Street, Urbana, Illinois, USA
| | - F Finelli
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- INFN, Sezione di Bologna, Via Irnerio 46, I-40126, Bologna, Italy
| | - S Fliescher
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - O Forni
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - M Frailis
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - A A Fraisse
- Department of Physics, Princeton University, Princeton, New Jersey, USA
| | - E Franceschi
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - A Frejsel
- Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
| | - S Galeotta
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - S Galli
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
| | - K Ganga
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - T Ghosh
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - M Giard
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - E Gjerløw
- Institute of Theoretical Astrophysics, University of Oslo, Blindern, Oslo, Norway
| | - S R Golwala
- California Institute of Technology, Pasadena, California, USA
| | - J González-Nuevo
- SISSA, Astrophysics Sector, via Bonomea 265, 34136, Trieste, Italy
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - K M Górski
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- Warsaw University Observatory, Aleje Ujazdowskie 4, 00-478 Warszawa, Poland
| | - S Gratton
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
| | - A Gregorio
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
- Dipartimento di Fisica, Università degli Studi di Trieste, via Alfonso Valerio 2, Trieste, Italy
- INFN/National Institute for Nuclear Physics, Via Valerio 2, I-34127 Trieste, Italy
| | - A Gruppuso
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - J E Gudmundsson
- Department of Physics, Princeton University, Princeton, New Jersey, USA
| | - M Halpern
- Department of Physics & Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, British Columbia, Canada
| | - F K Hansen
- Institute of Theoretical Astrophysics, University of Oslo, Blindern, Oslo, Norway
| | - D Hanson
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- CITA, University of Toronto, 60 St. George Street, Toronto, Ontario M5S 3H8, Canada
- McGill Physics, Ernest Rutherford Physics Building, McGill University, 3600 rue University, Montréal, Quebec, H3A 2T8, Canada
| | - D L Harrison
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
| | - M Hasselfield
- Department of Physics & Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, British Columbia, Canada
| | - G Helou
- California Institute of Technology, Pasadena, California, USA
| | | | - D Herranz
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - S R Hildebrandt
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - G C Hilton
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
| | - E Hivon
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
| | - M Hobson
- Astrophysics Group, Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 0HE, United Kingdom
| | - W A Holmes
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - W Hovest
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - V V Hristov
- California Institute of Technology, Pasadena, California, USA
| | - K M Huffenberger
- Department of Physics, Florida State University, Keen Physics Building, 77 Chieftan Way, Tallahassee, Florida, USA
| | - H Hui
- California Institute of Technology, Pasadena, California, USA
| | - G Hurier
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - K D Irwin
- Department of Physics, Stanford University, Stanford, California 94305, USA
- National Institute of Standards and Technology, Boulder, Colorado 80305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A H Jaffe
- Imperial College London, Astrophysics group, Blackett Laboratory, Prince Consort Road, London, SW7 2AZ, United Kingdom
| | - T R Jaffe
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - J Jewell
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - W C Jones
- Department of Physics, Princeton University, Princeton, New Jersey, USA
| | - M Juvela
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
| | - A Karakci
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - K S Karkare
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - J P Kaufman
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - B G Keating
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - S Kefeli
- California Institute of Technology, Pasadena, California, USA
| | - E Keihänen
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
| | - S A Kernasovskiy
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - R Keskitalo
- Computational Cosmology Center, Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - T S Kisner
- Lawrence Berkeley National Laboratory, Berkeley, California, USA
| | - R Kneissl
- European Southern Observatory, ESO Vitacura, Alonso de Cordova 3107, Vitacura, Casilla 19001, Santiago, Chile
- Atacama Large Millimeter/submillimeter Array, ALMA Santiago Central Offices, Alonso de Cordova 3107, Vitacura, Casilla 763 0355, Santiago, Chile
| | - J Knoche
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - L Knox
- Department of Physics, University of California, One Shields Avenue, Davis, California, USA
| | - J M Kovac
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - N Krachmalnicoff
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
| | - M Kunz
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- Département de Physique Théorique, Université de Genève, 24, Quai E. Ansermet, 1211 Genève 4, Switzerland
- African Institute for Mathematical Sciences, 6-8 Melrose Road, Muizenberg, Cape Town, South Africa
| | - C L Kuo
- Department of Physics, Stanford University, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - H Kurki-Suonio
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
| | - G Lagache
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- Aix Marseille Université, CNRS, LAM (Laboratoire d'Astrophysique de Marseille) UMR 7326, 13388, Marseille, France
| | - A Lähteenmäki
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
- Aalto University Metsähovi Radio Observatory and Department of Radio Science and Engineering, P.O. Box 13000, FI-00076 AALTO, Finland
| | - J-M Lamarre
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - A Lasenby
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
- Astrophysics Group, Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 0HE, United Kingdom
| | - M Lattanzi
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Via Saragat 1, 44122 Ferrara, Italy
| | - C R Lawrence
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - E M Leitch
- University of Chicago, Chicago, Illinois 60637, USA
| | - R Leonardi
- European Space Agency, ESAC, Planck Science Office, Camino bajo del Castillo, s/n, Urbanización Villafranca del Castillo, Villanueva de la Cañada, Madrid, Spain
| | - F Levrier
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - A Lewis
- Department of Physics and Astronomy, University of Sussex, Brighton BN1 9QH, United Kingdom
| | - M Liguori
- Dipartimento di Fisica e Astronomia G. Galilei, Università degli Studi di Padova, via Marzolo 8, 35131 Padova, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, via Marzolo 8, I-35131 Padova, Italy
| | - P B Lilje
- Institute of Theoretical Astrophysics, University of Oslo, Blindern, Oslo, Norway
| | - M Linden-Vørnle
- DTU Space, National Space Institute, Technical University of Denmark, Elektrovej 327, DK-2800 Kongens Lyngby, Denmark
| | - M López-Caniego
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
- European Space Agency, ESAC, Planck Science Office, Camino bajo del Castillo, s/n, Urbanización Villafranca del Castillo, Villanueva de la Cañada, Madrid, Spain
| | - P M Lubin
- Department of Physics, University of California, Santa Barbara, California, USA
| | - M Lueker
- California Institute of Technology, Pasadena, California, USA
| | - J F Macías-Pérez
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - B Maffei
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - D Maino
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - N Mandolesi
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Via Saragat 1, 44122 Ferrara, Italy
| | - A Mangilli
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - M Maris
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - P G Martin
- CITA, University of Toronto, 60 St. George Street, Toronto, Ontario M5S 3H8, Canada
| | - E Martínez-González
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - S Masi
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
| | - P Mason
- California Institute of Technology, Pasadena, California, USA
| | - S Matarrese
- Dipartimento di Fisica e Astronomia G. Galilei, Università degli Studi di Padova, via Marzolo 8, 35131 Padova, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, via Marzolo 8, I-35131 Padova, Italy
- Gran Sasso Science Institute, INFN, viale F. Crispi 7, 67100L'Aquila, Italy
| | - K G Megerian
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - P R Meinhold
- Department of Physics, University of California, Santa Barbara, California, USA
| | - A Melchiorri
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
- INFN, Sezione di Roma 1, Università di Roma Sapienza, Piazzale Aldo Moro 2, 00185, Roma, Italy
| | - L Mendes
- European Space Agency, ESAC, Planck Science Office, Camino bajo del Castillo, s/n, Urbanización Villafranca del Castillo, Villanueva de la Cañada, Madrid, Spain
| | - A Mennella
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - M Migliaccio
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
| | - S Mitra
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- IUCAA, Post Bag 4, Ganeshkhind, Pune University Campus, Pune 411 007, India
| | - M-A Miville-Deschênes
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- CITA, University of Toronto, 60 St. George Street, Toronto, Ontario M5S 3H8, Canada
| | - A Moneti
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
| | - L Montier
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - G Morgante
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - D Mortlock
- Imperial College London, Astrophysics group, Blackett Laboratory, Prince Consort Road, London, SW7 2AZ, United Kingdom
| | - A Moss
- School of Physics and Astronomy, University of Nottingham, Nottingham NG7 2RD, United Kingdom
| | - D Munshi
- School of Physics and Astronomy, Cardiff University, Queens Buildings, The Parade, Cardiff, CF24 3AA, United Kingdom
| | - J A Murphy
- National University of Ireland, Department of Experimental Physics, Maynooth, County Kildare, Ireland
| | - P Naselsky
- Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
- Discovery Center, Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
| | - F Nati
- Department of Physics, Princeton University, Princeton, New Jersey, USA
| | - P Natoli
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Dipartimento di Fisica e Scienze della Terra, Università di Ferrara, Via Saragat 1, 44122 Ferrara, Italy
- Agenzia Spaziale Italiana Science Data Center, Via del Politecnico snc, 00133, Roma, Italy
| | - C B Netterfield
- Department of Astronomy and Astrophysics, University of Toronto, 50 Saint George Street, Toronto, Ontario, Canada
| | - H T Nguyen
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - H U Nørgaard-Nielsen
- DTU Space, National Space Institute, Technical University of Denmark, Elektrovej 327, DK-2800 Kongens Lyngby, Denmark
| | - F Noviello
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - D Novikov
- Lebedev Physical Institute of the Russian Academy of Sciences, Astro Space Centre, 84/32 Profsoyuznaya st., Moscow, GSP-7, 117997, Russia
| | - I Novikov
- Niels Bohr Institute, Blegdamsvej 17, Copenhagen, Denmark
- Lebedev Physical Institute of the Russian Academy of Sciences, Astro Space Centre, 84/32 Profsoyuznaya st., Moscow, GSP-7, 117997, Russia
| | - R O'Brient
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - R W Ogburn
- Department of Physics, Stanford University, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - A Orlando
- Department of Physics, University of California at San Diego, La Jolla, California 92093, USA
| | - L Pagano
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
- INFN, Sezione di Roma 1, Università di Roma Sapienza, Piazzale Aldo Moro 2, 00185, Roma, Italy
| | - F Pajot
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - R Paladini
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, California 91125, USA
| | - D Paoletti
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- INFN, Sezione di Bologna, Via Irnerio 46, I-40126, Bologna, Italy
| | - B Partridge
- Haverford College Astronomy Department, 370 Lancaster Avenue, Haverford, Pennsylvania, USA
| | - F Pasian
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - G Patanchon
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - T J Pearson
- California Institute of Technology, Pasadena, California, USA
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, California 91125, USA
| | - O Perdereau
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - L Perotto
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - V Pettorino
- HGSFP and University of Heidelberg, Theoretical Physics Department, Philosophenweg 16, 69120, Heidelberg, Germany
| | - F Piacentini
- Dipartimento di Fisica, Università La Sapienza, Piazzale Aldo Moro 2, Roma, Italy
| | - M Piat
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
| | - D Pietrobon
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | | | - E Pointecouteau
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - G Polenta
- Agenzia Spaziale Italiana Science Data Center, Via del Politecnico snc, 00133, Roma, Italy
- INAF-Osservatorio Astronomico di Roma, via di Frascati 33, Monte Porzio Catone, Italy
| | - N Ponthieu
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- IPAG: Institut de Planétologie et d'Astrophysique de Grenoble, Université Grenoble Alpes, IPAG, F-38000 Grenoble, France, CNRS, IPAG, F-38000 Grenoble, France
| | - G W Pratt
- Laboratoire AIM, IRFU/Service d'Astrophysique-CEA/DSM-CNRS-Université Paris Diderot, Bâtiment 709, CEA-Saclay, F-91191 Gif-sur-Yvette Cedex, France
| | - S Prunet
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
| | - C Pryke
- Minnesota Institute for Astrophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - J-L Puget
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - J P Rachen
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
- Department of Astrophysics/IMAPP, Radboud University Nijmegen, P.O. Box 9010, 6500 GL Nijmegen, The Netherlands
| | - W T Reach
- Universities Space Research Association, Stratospheric Observatory for Infrared Astronomy, MS 232-11, Moffett Field, California 94035, USA
| | - R Rebolo
- Instituto de Astrofísica de Canarias, C/Vía Láctea s/n, La Laguna, Tenerife, Spain
- Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
- Departamento Astrofísica, Universidad de La Laguna (ULL), E-38206 La Laguna, Tenerife, Spain
| | - M Reinecke
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - M Remazeilles
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - C Renault
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - A Renzi
- Dipartimento di Matematica, Università di Roma Tor Vergata, Via della Ricerca Scientifica, 1, Roma, Italy
- INFN, Sezione di Roma 2, Università di Roma Tor Vergata, Via della Ricerca Scientifica, 1, Roma, Italy
| | - S Richter
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - I Ristorcelli
- Université de Toulouse, UPS-OMP, IRAP, F-31028 Toulouse cedex 4, France
- CNRS, IRAP, 9 Avenue colonel Roche, BP 44346, F-31028 Toulouse cedex 4, France
| | - G Rocha
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - M Rossetti
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - G Roudier
- APC, AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/lrfu, Observatoire de Paris, Sorbonne Paris Cité, 10, rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- LERMA, CNRS, Observatoire de Paris, 61 Avenue de l'Observatoire, Paris, France
| | - M Rowan-Robinson
- Imperial College London, Astrophysics group, Blackett Laboratory, Prince Consort Road, London, SW7 2AZ, United Kingdom
| | - J A Rubiño-Martín
- Instituto de Astrofísica de Canarias, C/Vía Láctea s/n, La Laguna, Tenerife, Spain
- Departamento Astrofísica, Universidad de La Laguna (ULL), E-38206 La Laguna, Tenerife, Spain
| | - B Rusholme
- Infrared Processing and Analysis Center, California Institute of Technology, Pasadena, California 91125, USA
| | - M Sandri
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - D Santos
- Laboratoire de Physique Subatomique et Cosmologie, Université Grenoble-Alpes, CNRS/IN2P3, 53, rue des Martyrs, 38026 Grenoble Cedex, France
| | - M Savelainen
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
| | - G Savini
- Optical Science Laboratory, University College London, Gower Street, London, United Kingdom
| | - R Schwarz
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - D Scott
- Department of Physics & Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, British Columbia, Canada
| | - M D Seiffert
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - C D Sheehy
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
| | - L D Spencer
- School of Physics and Astronomy, Cardiff University, Queens Buildings, The Parade, Cardiff, CF24 3AA, United Kingdom
| | - Z K Staniszewski
- California Institute of Technology, Pasadena, California, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - V Stolyarov
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
- Astrophysics Group, Cavendish Laboratory, University of Cambridge, J J Thomson Avenue, Cambridge CB3 0HE, United Kingdom
- Special Astrophysical Observatory, Russian Academy of Sciences, Nizhnij Arkhyz, Zelenchukskiy region, Karachai-Cherkessian Republic, 369167, Russia
| | - R Sudiwala
- School of Physics and Astronomy, Cardiff University, Queens Buildings, The Parade, Cardiff, CF24 3AA, United Kingdom
| | - R Sunyaev
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
- Space Research Institute (IKI), Russian Academy of Sciences, Profsoyuznaya Street, 84/32, Moscow, 117997, Russia
| | - D Sutton
- Institute of Astronomy, University of Cambridge, Madingley Road, Cambridge CB3 0HA, United Kingdom
- Kavli Institute for Cosmology Cambridge, Madingley Road, Cambridge, CB3 0HA, United Kingdom
| | - A-S Suur-Uski
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
| | - J-F Sygnet
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
| | - J A Tauber
- European Space Agency, ESTEC, Keplerlaan 1, 2201 AZ Noordwijk, The Netherlands
| | - G P Teply
- California Institute of Technology, Pasadena, California, USA
| | - L Terenzi
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Facoltà di Ingegneria, Università degli Studi e-Campus, Via Isimbardi 10, Novedrate (CO), 22060, Italy
| | - K L Thompson
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - L Toffolatti
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
- Departamento de Física, Universidad de Oviedo, Avda. Calvo Sotelo s/n, Oviedo, Spain
| | - J E Tolan
- Department of Physics, Stanford University, Stanford, California 94305, USA
| | - M Tomasi
- Dipartimento di Fisica, Università degli Studi di Milano, Via Celoria, 16, Milano, Italy
- INAF/IASF Milano, Via E. Bassini 15, Milano, Italy
| | - M Tristram
- LAL, Université Paris-Sud, CNRS/IN2P3, Orsay, France
| | - M Tucci
- Département de Physique Théorique, Université de Genève, 24, Quai E. Ansermet, 1211 Genève 4, Switzerland
| | - A D Turner
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
- University of Chicago, Chicago, Illinois 60637, USA
| | - L Valenziano
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - J Valiviita
- Department of Physics, Gustaf Hällströmin katu 2a, University of Helsinki, Helsinki, Finland
- Helsinki Institute of Physics, Gustaf Hällströmin katu 2, University of Helsinki, Helsinki, Finland
| | - B Van Tent
- Laboratoire de Physique Théorique, Université Paris-Sud 11 & CNRS, Bâtiment 210, 91405 Orsay, France
| | - L Vibert
- Institut d'Astrophysique Spatiale, CNRS (UMR8617) Université Paris-Sud 11, Bâtiment 121, Orsay, France
| | - P Vielva
- Instituto de Física de Cantabria (CSIC-Universidad de Cantabria), Avenida de los Castros s/n, Santander, Spain
| | - A G Vieregg
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
- Department of Physics, Enrico Fermi Institute, University of Chicago, Chicago, Illinois 60637, USA
| | - F Villa
- INAF/IASF Bologna, Via Gobetti 101, Bologna, Italy
| | - L A Wade
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - B D Wandelt
- Institut d'Astrophysique de Paris, CNRS (UMR7095), 98 bis Boulevard Arago, F-75014, Paris, France
- UPMC Université de Paris 06, UMR7095, 98 bis Boulevard Arago, F-75014, Paris, France
- Department of Physics, University of Illinois at Urbana-Champaign, 1110 West Green Street, Urbana, Illinois, USA
| | - R Watson
- Jodrell Bank Centre for Astrophysics, Alan Turing Building, School of Physics and Astronomy, The University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
| | - A C Weber
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - I K Wehus
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California, USA
| | - M White
- Department of Physics, University of California, Berkeley, California, USA
| | - S D M White
- Max-Planck-Institut für Astrophysik, Karl-Schwarzschild-Strasse 1, 85741 Garching, Germany
| | - J Willmert
- School of Physics and Astronomy, University of Minnesota, Minneapolis, Minnesota 55455, USA
| | - C L Wong
- Harvard-Smithsonian Center for Astrophysics, 60 Garden Street MS 42, Cambridge, Massachusetts 02138, USA
| | - K W Yoon
- Department of Physics, Stanford University, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, California 94025, USA
| | - D Yvon
- DSM/Irfu/SPP, CEA-Saclay, F-91191 Gif-sur-Yvette Cedex, France
| | - A Zacchei
- INAF-Osservatorio Astronomico di Trieste, Via G.B. Tiepolo 11, Trieste, Italy
| | - A Zonca
- Department of Physics, University of California, Santa Barbara, California, USA
| |
Collapse
|
44
|
Abstract
BACKGROUND The ability to accurately recognize facial expressions of pain is known to affect clinical decision making and delivery of care. Although recognition accuracy for facial expressions of pain is well above chance level, substantial shortcomings have also been reported which stress the need to look for methods to improve recognition accuracy. Based on findings that pain is encoded in different facial activity patterns, we wanted to investigate whether training observers to recognize these various faces of pain might improve their ability to accurately recognize pain. METHODS Participants (55 male, 65 female) were randomly assigned to one of the three training groups: 'different patterns group' (calling attention to the various faces of pain); 'prototypical group' (calling attention to the prototypical expression of pain); and 'control group' (being informed about pain in general). For outcome assessments, participants viewed videos of individuals experiencing either pain, disgust or a neutral condition and had to infer what the individual in the video was experiencing. These videos were presented twice (before and after the training). RESULTS The 'different patterns group' benefited the most from its training, with recognition accuracy for pain increasing significantly more compared to the other groups. The 'prototypical' group also showed improved recognition accuracy for pain, however, this improved recogntition was cancelled out by decreased recognition accuracy for disgust. CONCLUSIONS Raising awareness in observers that different combinations of facial movements (different faces of pain) are equivalent signals of pain through a brief training procedure can improve recognition accuracy for pain substantially.
Collapse
Affiliation(s)
- M Kunz
- Physiological Psychology, Otto-Friedrich University Bamberg, Germany
| | - S Lautenbacher
- Physiological Psychology, Otto-Friedrich University Bamberg, Germany
| |
Collapse
|
45
|
Sieker JT, Kunz M, Weißenberger M, Gilbert F, Frey S, Rudert M, Steinert AF. Direct bone morphogenetic protein 2 and Indian hedgehog gene transfer for articular cartilage repair using bone marrow coagulates. Osteoarthritis Cartilage 2015; 23:433-42. [PMID: 25463442 DOI: 10.1016/j.joca.2014.11.008] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2014] [Revised: 11/01/2014] [Accepted: 11/05/2014] [Indexed: 02/02/2023]
Abstract
OBJECTIVE Bone morphogenetic protein 2 (BMP-2, encoded by BMP2) and Indian hedgehog protein (IHH, encoded by IHH) are well known regulators of chondrogenesis and chondrogenic hypertrophy. Despite being a potent chondrogenic factor BMP-2 was observed to induce chondrocyte hypertrophy in osteoarthritis (OA), growth plate cartilage and adult mesenchymal stem cells (MSCs). IHH might induce chondrogenic differentiation through different intracellular signalling pathways without inducing subsequent chondrocyte hypertrophy. The primary objective of this study is to test the efficacy of direct BMP2 and IHH gene delivery via bone marrow coagulates to influence histological repair cartilage quality in vivo. METHOD Vector-laden autologous bone marrow coagulates with 10(11) adenoviral vector particles encoding BMP2, IHH or the Green fluorescent protein (GFP) were delivered to 3.2 mm osteochondral defects in the trochlea of rabbit knees. After 13 weeks the histological repair cartilage quality was assessed using the ICRS II scoring system and the type II collagen positive area. RESULTS IHH treatment resulted in superior histological repair cartilage quality than GFP controls in all of the assessed parameters (with P < 0.05 in five of 14 assessed parameters). Results of BMP2 treatment varied substantially, including severe intralesional bone formation in two of six joints after 13 weeks. CONCLUSION IHH gene transfer is effective to improve repair cartilage quality in vivo, whereas BMP2 treatment, carried the risk intralesional bone formation. Therefore IHH protein can be considered as an attractive alternative candidate growth factor for further preclinical research and development towards improved treatments for articular cartilage defects.
Collapse
Affiliation(s)
- J T Sieker
- Department of Orthopaedic Surgery, König-Ludwig-Haus, Julius-Maximilians-University of Würzburg, Germany.
| | - M Kunz
- Department of Orthopaedic Surgery, König-Ludwig-Haus, Julius-Maximilians-University of Würzburg, Germany.
| | - M Weißenberger
- Department of Orthopaedic Surgery, König-Ludwig-Haus, Julius-Maximilians-University of Würzburg, Germany.
| | - F Gilbert
- Department of Orthopaedic Surgery, König-Ludwig-Haus, Julius-Maximilians-University of Würzburg, Germany; Department of Trauma, Hand, Plastic and Reconstructive Surgery, Julius-Maximilians-University of Würzburg, Germany.
| | - S Frey
- Department of Trauma, Hand, Plastic and Reconstructive Surgery, Julius-Maximilians-University of Würzburg, Germany.
| | - M Rudert
- Department of Orthopaedic Surgery, König-Ludwig-Haus, Julius-Maximilians-University of Würzburg, Germany.
| | - A F Steinert
- Department of Orthopaedic Surgery, König-Ludwig-Haus, Julius-Maximilians-University of Würzburg, Germany.
| |
Collapse
|
46
|
Wingenfeld K, Wolf S, Kunz M, Krieg JC, Lautenbacher S. No effects of hydrocortisone and dexamethasone on pain sensitivity in healthy individuals. Eur J Pain 2014; 19:834-41. [PMID: 25380413 DOI: 10.1002/ejp.610] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/23/2014] [Indexed: 02/01/2023]
Abstract
BACKGROUND There is some evidence that stress-induced cortisol increase leads to a decrease in pain, while lowering cortisol levels enhances pain sensitivity, but no study has yet investigated both pharmacological enhancement and reduction of cortisol levels in the same individuals. METHODS Firstly, we tested in 16 healthy individuals whether the treatment with hydrocortisone and dexamethasone, respectively, results in altered pain thresholds. Secondly, we aimed to test whether hormone effects are different across the pain range by using ratings for pain stimuli with varying intensity; and thirdly, we tested whether cortisol levels influence the discrimination ability for painful stimuli. RESULTS Despite substantial effects of dexamethasone and hydrocortisone administration on cortisol levels, no effect of these drugs was seen in terms of pain sensitivity (pain threshold, pain rating, pain discrimination ability), although comprehensively examined. However, in the placebo condition, a significant negative correlation between cortisol and pain thresholds was seen. Similarly, there were also strong negative associations between cortisol levels in the placebo condition and pain thresholds after drug treatment (especially after hydrocortisone). CONCLUSION These findings suggest that short-term variations of cortisol do not influence pain sensitivity whereas, in general, high levels of cortisol are associated with increased pain sensitivity, at least for weak to moderate stimuli.
Collapse
Affiliation(s)
- K Wingenfeld
- Department of Psychiatry, Charité University Berlin, Campus Benjamin Franklin, Berlin, Germany
| | | | | | | | | |
Collapse
|
47
|
Kapczinski F, Magalhães PVS, Balanzá-Martinez V, Dias VV, Frangou S, Gama CS, Gonzalez-Pinto A, Grande I, Ha K, Kauer-Sant'Anna M, Kunz M, Kupka R, Leboyer M, Lopez-Jaramillo C, Post RM, Rybakowski JK, Scott J, Strejilevitch S, Tohen M, Vazquez G, Yatham L, Vieta E, Berk M. Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand 2014; 130:354-63. [PMID: 24961757 DOI: 10.1111/acps.12305] [Citation(s) in RCA: 161] [Impact Index Per Article: 16.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/30/2014] [Indexed: 12/14/2022]
Abstract
OBJECTIVE We discuss the rationale behind staging systems described specifically for bipolar disorders. Current applications, future directions and research gaps in clinical staging models for bipolar disorders are outlined. METHOD We reviewed the literature pertaining to bipolar disorders, focusing on the first episode onwards. We systematically searched data on staging models for bipolar disorders and allied studies that could inform the concept of staging. RESULTS We report on several dimensions that are relevant to staging concepts in bipolar disorder. We consider whether staging offers a refinement to current diagnoses by reviewing clinical studies of treatment and functioning and the potential utility of neurocognitive, neuroimaging and peripheral biomarkers. CONCLUSION Most studies to date indicate that globally defined late-stage patients have a worse overall prognosis and poorer response to standard treatment, consistent with patterns for end-stage medical disorders. We believe it is possible at this juncture to speak broadly of 'early'- and 'late'-stage bipolar disorder. Next steps require further collaborative efforts to consider the details of preillness onset and intermediary stages, and how many additional stages are optimal.
Collapse
Affiliation(s)
- F Kapczinski
- National Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Rachinger W, Kunz M, Thon N, Tonn JC, Kreth FW. O5.06 * CYSTIC CRANIOPHARYNGIOMAS: MICROSURGICAL OR STEREOTACTIC TREATMENT? Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Grande I, Magalhães PVS, Chendo I, Stertz L, Fries GR, Cereser KM, Cunha ÂBM, Gói P, Kunz M, Udina M, Martín-Santos R, Frey BN, Vieta E, Kapczinski F. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial. Acta Psychiatr Scand 2014; 129:393-400. [PMID: 23957567 DOI: 10.1111/acps.12192] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/11/2013] [Indexed: 12/21/2022]
Abstract
OBJECTIVE Brain-derived neurotrophic factor (BDNF) is consistently associated with acute mood episodes in bipolar disorder, but there is a lack of longitudinal data to support this hypothesis. In this 16-week open-label clinical trial, we tested the predictive role of BDNF Val66Met polymorphism on serum BDNF levels and the relationship of serum BDNF and clinical response in people with bipolar disorder during an acute illness episode. METHOD Sixty-four people with bipolar disorder who were medication-free at baseline and in an acute mood episode were recruited. They were matched with 64 healthy controls. Clinical evaluation, serum BDNF, and BDNF Val66Met polymorphism were determined at baseline, and change in serum BDNF was assessed in patients at weeks 2, 4, 8 and 16. RESULTS There were no differences between patients and controls in serum BDNF or in frequencies of the BDNF Val66Met polymorphism genotype at baseline. The multivariable model showed that Met carriers had a significantly different change in BDNF levels compared with Val homozygotes. Not achieving a complete remission was also associated with lower prospectively assessed BDNF levels. CONCLUSION This study provides the first longitudinal evidence that both the BDNF Val66Met polymorphism and remission status predict change in circulating BDNF levels.
Collapse
Affiliation(s)
- I Grande
- Bipolar Disorders Unit, IDIBAPS, CIBERSAM, Clinical Institute of Neurosciences, Hospital Clínic, University of Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Teepker M, Kunz M, Peters M, Kundermann B, Schepelmann K, Lautenbacher S. Endogenous pain inhibition during menstrual cycle in migraine. Eur J Pain 2014; 18:989-98. [DOI: 10.1002/j.1532-2149.2013.00444.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/22/2013] [Indexed: 11/11/2022]
Affiliation(s)
- M. Teepker
- Department of Neurology; Philipps-University of Marburg; Germany
| | - M. Kunz
- Department of Physiological Psychology; University of Bamberg; Germany
| | - M. Peters
- Department of Physiological Psychology; University of Bamberg; Germany
- Department of Child and Adolescent Psychiatry; Philipps-University of Marburg; Germany
| | - B. Kundermann
- Department of Psychiatry and Psychotherapy; Philipps-University of Marburg; Germany
| | - K. Schepelmann
- Department of Neurology; Philipps-University of Marburg; Germany
- Department of Neurology; Schlei-Klinikum Schleswig MLK; Germany
| | - S. Lautenbacher
- Department of Physiological Psychology; University of Bamberg; Germany
| |
Collapse
|